Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Ischemic Heart Disease

Free Subscription Articles published in J Am Coll Cardiol Retrieve available abstracts of 524 articles: HTML format

Single Articles

April 2024
1. BOROVAC JA
   Unlocking the Gates of ISCHEMIA: Moving Toward Personalized Angina Management for Chronic Coronary Syndrome.
   J Am Coll Cardiol. 2024;83:1367-1369.
   PubMed    
   
   
   
2. ARNOLD SV, Jones PG, Maron DJ, Cohen DJ, et al
   Variation in Health Status With Invasive vs Conservative Management of Chronic Coronary Disease.
   J Am Coll Cardiol. 2024;83:1353-1366.
   PubMed     Abstract available
   
   
   
3. SCHNEIDER PA, Olin JW
   Paclitaxel-Mortality Risk Hypothesis Debunked: What We Learned and How It Will Change Future Clinical Trials.
   J Am Coll Cardiol. 2024;83:1222-1224.
   PubMed    
   
   
   
4. KONTOS MC, de Lemos JA
   Chest Pain in the Emergency Department: Chasing Perfection.
   J Am Coll Cardiol. 2024;83:1191-1193.
   PubMed    
   
   
   
5. MAHLER SA, Ashburn NP, Supples MW, Hashemian T, et al
   Validation of the ACC Expert Consensus Decision Pathway for Patients With Chest Pain.
   J Am Coll Cardiol. 2024;83:1181-1190.
   PubMed     Abstract available
   
   
   
6. UDELL JA, Petrie MC, Jones WS, Anker SD, et al
   Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction.
   J Am Coll Cardiol. 2024 Apr 1:S0735-1097(24)06757.
   PubMed     Abstract available
   
   
   
7. MINHAS AMK, Mathew RO, Sperling LS, Nambi V, et al
   Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States.
   J Am Coll Cardiol. 2024 Apr 1:S0735-1097(24)00940.
   PubMed    
   
   
   March 2024
8. MORENO PR, Fuster V
   JACC Focus Seminar on Mechanical Complications of Acute Myocardial Infarction.
   J Am Coll Cardiol. 2024 Mar 30:S0735-1097(24)06820.
   PubMed    
   
   
   
9. AI S, Ye S, Li G, Leng Y, et al
   Association of Disrupted Delta Wave Activity During Sleep With Long-Term Cardiovascular Disease and Mortality.
   J Am Coll Cardiol. 2024 Mar 28:S0735-1097(24)00484.
   PubMed     Abstract available
   
   
   
10. ALSHAHRANI NS, Hartley A, Howard J, Hajhosseiny R, et al
    Remote Acute Assessment of Cardiac Patients Post-Acute Coronary Syndrome (TELE-ACS): A Randomized Controlled Trial.
    J Am Coll Cardiol. 2024 Mar 28:S0735-1097(24)06709.
    PubMed     Abstract available
    
    
    
11. ELIAS P, Jain S, Poterucha T, Randazzo M, et al
    Artificial Intelligence for Cardiovascular Care - Part 1: Advances: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024 Mar 26:S0735-1097(24)06742.
    PubMed     Abstract available
    
    
    
12. JAIN S, Elias P, Poterucha T, Randazzo M, et al
    Artificial Intelligence in Cardiovascular Care - Part 2: Applications: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024 Mar 26:S0735-1097(24)06744.
    PubMed     Abstract available
    
    
    
13. POVSIC TJ, Korjian S, Bahit MC, Chi G, et al
    Effect of CSL112 on Recurrent Myocardial Infarction and Cardiovascular Death: Insights from the AEGIS-II Trial.
    J Am Coll Cardiol. 2024 Mar 25:S0735-1097(24)06702.
    PubMed     Abstract available
    
    
    
14. BATCHELOR WB, Damluji AA
    Rehospitalization After PCI vs CABG for Left Main Disease: Refocusing Our Lens.
    J Am Coll Cardiol. 2024;83:1082-1084.
    PubMed    
    
    
    
15. KOSMIDOU I, Shahim B, Dressler O, Redfors B, et al
    Incidence, Predictors, and Impact of Hospital Readmission After Revascularization for Left Main Coronary Disease.
    J Am Coll Cardiol. 2024;83:1073-1081.
    PubMed     Abstract available
    
    
    
16. BRIGUORI C, Quintavalle C, Mariano E, D'Agostino A, et al
    Kidney Injury After Minimal Radiographic Contrast Administration in Patients With Acute Coronary Syndromes.
    J Am Coll Cardiol. 2024;83:1059-1069.
    PubMed     Abstract available
    
    
    
17. SZAREK M, Bhatt DL, Miller M, Brinton EA, et al
    Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl.
    J Am Coll Cardiol. 2024 Mar 15:S0735-1097(24)00384.
    PubMed     Abstract available
    
    
    
18. LI Z, Wereski R, Anand A, Lowry MT, et al
    Uniform or Sex-Specific Cardiac Troponin Thresholds to Rule-out Myocardial Infarction at Presentation.
    J Am Coll Cardiol. 2024 Mar 13:S0735-1097(24)00912.
    PubMed     Abstract available
    
    
    
19. WILSON BH, Wu JC, Fang JC, Hurwitz JL, et al
    Modernizing Cardiovascular Medicine Board Certification: Leveraging Innovation and Strengthening Continuous Competency and Professional Growth.
    J Am Coll Cardiol. 2024 Mar 13:S0735-1097(24)00473.
    PubMed    
    
    
    
20. OKOH AK, Amponsah MKD, Cheffet-Walsh S, Patel M, et al
    Prevalence of Cardiovascular Disease and Risk Factors among National Football League Alumni and Family Members.
    J Am Coll Cardiol. 2024 Mar 12:S0735-1097(24)00988.
    PubMed     Abstract available
    
    
    
21. BLAHA MJ, Bhatia HS
    Lipoprotein(a), Residual Cardiovascular Risk, and the Search for Targeted Therapy.
    J Am Coll Cardiol. 2024 Mar 9:S0735-1097(24)00944.
    PubMed    
    
    
    
22. HANSEN MK, Olesen KKW, Gyldenkerne C, Thrane PG, et al
    Eligibility for and Preventive Potential of Semaglutide in Overweight and Obese Patients With Myocardial Infarction.
    J Am Coll Cardiol. 2024;83:956-958.
    PubMed    
    
    
    
23. SCHWANN TA, Engelman DT
    Anemia and Sex Disparity in CABG Mortality: In Search of a Grand Unified Theory.
    J Am Coll Cardiol. 2024;83:929-931.
    PubMed    
    
    
    
24. MANN DL, Nicolas J, Claggett B, Miao ZM, et al
    Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI.
    J Am Coll Cardiol. 2024;83:904-914.
    PubMed     Abstract available
    
    
    
25. MUKHERJEE D
    Is There a Role for Routine Stress Testing After Multivessel or Left Main PCI?
    J Am Coll Cardiol. 2024;83:901-903.
    PubMed    
    
    
    
26. LEE JM, Kim H, Park YS, Jo HH, et al
    Surveillance Stress Testing After Percutaneous Intervention for Patients With Multivessel or Left Main Coronary Disease.
    J Am Coll Cardiol. 2024;83:890-900.
    PubMed     Abstract available
    
    
    
27. HARIK L, Habib RH, Dimagli A, Rahouma M, et al
    Intraoperative Anemia Mediates Sex Disparity in Operative Mortality After Coronary Artery Bypass Grafting.
    J Am Coll Cardiol. 2024;83:918-928.
    PubMed     Abstract available
    
    
    
28. BERMAN AN, Biery DW, Besser SA, Singh A, et al
    Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients With or Without Baseline Atherosclerotic Cardiovascular Disease.
    J Am Coll Cardiol. 2024;83:873-886.
    PubMed     Abstract available
    
    
    February 2024
29. BOTTINOR W, Im C, Doody DR, Armenian SH, et al
    Mortality After Major Cardiovascular Events in Survivors of Childhood Cancer.
    J Am Coll Cardiol. 2024;83:827-838.
    PubMed     Abstract available
    
    
    
30. MARTINEZ MW, Ackerman MJ, Annas GJ, Baggish AL, et al
    Sports Participation by Athletes With Cardiovascular Disease.
    J Am Coll Cardiol. 2024;83:865-868.
    PubMed    
    
    
    
31. JI H, Gulati M, Huang TY, Kwan AC, et al
    Sex Differences in Association of Physical Activity With All-Cause and Cardiovascular Mortality.
    J Am Coll Cardiol. 2024;83:783-793.
    PubMed     Abstract available
    
    
    
32. MADDAHI J
    Reply: (18)F-Flurpiridaz Myocardial Perfusion PET, What Is it That Matters? Diagnostic or Prognostic Accuracy?
    J Am Coll Cardiol. 2024;83:e69.
    PubMed    
    
    
    
33. CAOBELLI F
    (18)F-Flurpiridaz Myocardial Perfusion PET, What Is it That Matters? Diagnostic or Prognostic Accuracy?
    J Am Coll Cardiol. 2024;83:e67.
    PubMed    
    
    
    
34. YOO JE, Kim M, Kim B, Lee H, et al
    Increased Risk of Myocardial Infarction, Heart Failure, and Atrial Fibrillation After Spinal Cord Injury.
    J Am Coll Cardiol. 2024;83:741-751.
    PubMed     Abstract available
    
    
    
35. NATARAJAN P, Patel AP
    Differences in Circulating Progenitor Cells and Risk of Atherosclerotic Cardiovascular Disease in South Asian Individuals.
    J Am Coll Cardiol. 2024;83:770-771.
    PubMed    
    
    
    
36. EIKELBOOM JW, Mundl H, Alexander JH, Caso V, et al
    Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials.
    J Am Coll Cardiol. 2024;83:669-678.
    PubMed     Abstract available
    
    
    
37. MCCLINTICK DJ, O'Donoghue ML, De Ferrari GM, Ferreira J, et al
    Long-Term Efficacy of Evolocumab in Patients With or Without Multivessel Coronary Disease.
    J Am Coll Cardiol. 2024;83:652-664.
    PubMed     Abstract available
    
    
    
38. NAMBI V, Abushamat LA
    LDL-C Lowering in Prevention of Atherosclerotic Cardiovascular Disease: Another Step Forward in This Lifelong Marathon.
    J Am Coll Cardiol. 2024;83:665-668.
    PubMed    
    
    
    
39. BELMONTE M, Gallinoro E, Pijls NHJ, Bertolone DT, et al
    Measuring Absolute Coronary Flow and Microvascular Resistance by Thermodilution: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024;83:699-709.
    PubMed     Abstract available
    
    
    
40. BESS C, Ferdinand D, Underwood P, Ivy D, et al
    Promoting Cardiovascular Health Equity: Association of Black Cardiologists Practical Model for Community-Engaged Partnerships.
    J Am Coll Cardiol. 2024;83:632-636.
    PubMed    
    
    
    
41. VARMA N, Han JK, Passman R, Rosman LA, et al
    Promises and Perils of Consumer Mobile Technologies in Cardiovascular Care: JACC Scientific Statement.
    J Am Coll Cardiol. 2024;83:611-631.
    PubMed     Abstract available
    
    
    
42. SABA PS, Al Kindi S, Nasir K
    Redefining Cardiovascular Risk Assessment as a Spectrum: From Binary to Continuous.
    J Am Coll Cardiol. 2024;83:574-576.
    PubMed    
    
    
    
43. MOK Y, Dardari Z, Sang Y, Hu X, et al
    Universal Risk Prediction for Individuals With and Without Atherosclerotic Cardiovascular Disease.
    J Am Coll Cardiol. 2024;83:562-573.
    PubMed     Abstract available
    
    
    
44. SCHUMACHER KR, Vitale C
    It Is Shocking How Little We Have Talked About Cardiogenic Shock in Pediatrics.
    J Am Coll Cardiol. 2024;83:609-610.
    PubMed    
    
    
    
45. PURI K, Jentzer JC, Spinner JA, Hope KD, et al
    Clinical Presentation, Classification, and Outcomes of Cardiogenic Shock in Children.
    J Am Coll Cardiol. 2024;83:595-608.
    PubMed     Abstract available
    
    
    
46. DIMAIO JM, McCullough KA, Widmer RJ
    A Post Hoc Analysis of ISCHEMIA: Are All Events Created Equal?
    J Am Coll Cardiol. 2024;83:559-561.
    PubMed    
    
    
    January 2024
47. CHHATRIWALLA AK, Cohen DJ, Vemulapalli S, Vekstein A, et al
    Transcatheter Edge-to-Edge Repair in COAPT-Ineligible Patients With Functional Mitral Regurgitation.
    J Am Coll Cardiol. 2024;83:488-499.
    PubMed     Abstract available
    
    
    
48. LEVINE GN
    Erectile Dysfunction and Coronary Artery Disease: Unfortunate Bedfellows.
    J Am Coll Cardiol. 2024;83:427-429.
    PubMed    
    
    
    
49. TROLLE LAGERROS Y, Grotta A, Freyland S, Grannas D, et al
    Risk of Death in Patients With Coronary Artery Disease Taking Nitrates and Phosphodiesterase-5 Inhibitors.
    J Am Coll Cardiol. 2024;83:417-426.
    PubMed     Abstract available
    
    
    
50. CAPODANNO D, Spagnolo M
    Optical Coherence Tomography or Intravascular Ultrasound for Complex PCI: Different Approaches, Similar Outcomes.
    J Am Coll Cardiol. 2024;83:414-416.
    PubMed    
    
    
    
51. BJORNSON E, Adiels M, Taskinen MR, Burgess S, et al
    Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis.
    J Am Coll Cardiol. 2024;83:385-395.
    PubMed     Abstract available
    
    
    
52. MARSTON NA, Melloni GEM, Murphy SA, Morze J, et al
    Per-Particle Cardiovascular Risk of Lipoprotein(a) vs Non-Lp(a) Apolipoprotein B-Containing Lipoproteins.
    J Am Coll Cardiol. 2024;83:470-472.
    PubMed    
    
    
    
53. MADDOX TM, Fry ETA, Wilson BH
    The Cardiovascular Workforce Crisis: Navigating the Present, Planning for the Future.
    J Am Coll Cardiol. 2024;83:466-469.
    PubMed    
    
    
    
54. FORD ND, DeSisto CL, Womack LS, Galang RR, et al
    Hospitalization With Cardiovascular Conditions in the Postpartum Year Among Commercially Insured Women in the U.S.
    J Am Coll Cardiol. 2024;83:382-384.
    PubMed    
    
    
    
55. SINHA A, Dutta U, Demir OM, De Silva K, et al
    Rethinking False Positive Exercise Electrocardiographic Stress Tests by Assessing Coronary Microvascular Function.
    J Am Coll Cardiol. 2024;83:291-299.
    PubMed     Abstract available
    
    
    
56. BATES ER
    Clinically Significant Differences Between P2Y(12) Inhibitor Monotherapy and Aspirin Monotherapy Have Yet to Be Demonstrated.
    J Am Coll Cardiol. 2024;83:e9-e10.
    PubMed    
    
    
    
57. BELLEMAIN-APPAIX A, Montalescot G
    Clopidogrel for Long-Term Secondary Prevention After Coronary Artery Stenting.
    J Am Coll Cardiol. 2024;83:32-34.
    PubMed    
    
    
    December 2023
58. MENSAH GA, Fuster V, Murray CJL, Roth GA, et al
    Global Burden of Cardiovascular Diseases and Risks, 1990-2022.
    J Am Coll Cardiol. 2023;82:2350-2473.
    PubMed    
    
    
    
59. KUNO T, Kiyohara Y, Maehara A, Ueyama HA, et al
    Comparison of Intravascular Imaging, Functional, or Angiographically Guided Coronary Intervention.
    J Am Coll Cardiol. 2023;82:2167-2176.
    PubMed     Abstract available
    
    
    
60. GRINES CL, DuPont A
    Lesion Selection and Optimizing PCI: Intravascular Hemodynamics, Imaging, or Both?
    J Am Coll Cardiol. 2023;82:2177-2178.
    PubMed    
    
    
    
61. MEZUE K, Abohashem S, Osborne MT, Tawakol A, et al
    Reply: Causal Pathway of Alcohol Intake: Stress-Related Neuronal Activity and Cardiovascular Risk.
    J Am Coll Cardiol. 2023;82:e227-e228.
    PubMed    
    
    
    
62. MOHANANNAIR GEETHADEVI G
    Causal Pathway of Alcohol Intake: Stress-Related Neuronal Activity and Cardiovascular Risk.
    J Am Coll Cardiol. 2023;82:e225.
    PubMed    
    
    
    
63. GAUDINO M, Pocock S, Rockhold F, Bhatt DL, et al
    Reporting Extended Follow-Up in Cardiovascular Clinical Trials.
    J Am Coll Cardiol. 2023;82:2246-2250.
    PubMed    
    
    
    November 2023
64. PAI RG
    Potential Mechanisms of Troponin Release in Stable Coronary Artery Disease.
    J Am Coll Cardiol. 2023;82:e215.
    PubMed    
    
    
    
65. KURLANSKY PA, Bittl JA
    Learning From Machines to Predict Mortality After Surgical or Percutaneous Revascularization.
    J Am Coll Cardiol. 2023;82:2125-2127.
    PubMed    
    
    
    
66. NINOMIYA K, Kageyama S, Shiomi H, Kotoku N, et al
    Can Machine Learning Aid the Selection of Percutaneous vs Surgical Revascularization?
    J Am Coll Cardiol. 2023;82:2113-2124.
    PubMed     Abstract available
    
    
    
67. WERESKI R, Chapman AR, Mills NL
    Reply: Potential Mechanisms of Troponin Release in Stable Coronary Artery Disease.
    J Am Coll Cardiol. 2023;82:e217.
    PubMed    
    
    
    
68. O'KEEFE EL, Lavie CJ, Elagizi A, Milani RV, et al
    Omega 3, Atrial Fibrillation, and Cardiovascular Outcomes.
    J Am Coll Cardiol. 2023;82:e201-e202.
    PubMed    
    
    
    
69. KULKARNI VT
    Psychological Safety in Cardiovascular Fellowship Training.
    J Am Coll Cardiol. 2023;82:2063-2067.
    PubMed    
    
    
    
70. BARRABES JA, Rodenas-Alesina E, Mila L
    Delineating the Benefits of an Invasive Strategy in Octogenarians With Non-ST-Segment Elevation Acute Coronary Syndromes.
    J Am Coll Cardiol. 2023;82:2031-2033.
    PubMed    
    
    
    
71. BERG ES, Tegn NK, Abdelnoor M, Roysland K, et al
    Long-Term Outcomes of Invasive vs Conservative Strategies for Older Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.
    J Am Coll Cardiol. 2023;82:2021-2030.
    PubMed     Abstract available
    
    
    
72. MAZIDI M, Wright N, Yao P, Kartsonaki C, et al
    Plasma Proteomics to Identify Drug Targets for Ischemic Heart Disease.
    J Am Coll Cardiol. 2023;82:1906-1920.
    PubMed     Abstract available
    
    
    
73. BURGER PM, Visseren FLJ, Dorresteijn JAN
    Reply: C-Reactive Protein and Heart Failure in Patients With Established Cardiovascular Disease: Evidence From UK Biobank.
    J Am Coll Cardiol. 2023;82:e193.
    PubMed    
    
    
    
74. MORZE J, Rynkiewicz A
    C-Reactive Protein and Heart Failure in Patients With Established Cardiovascular Disease: Evidence From UK Biobank.
    J Am Coll Cardiol. 2023;82:e191-e192.
    PubMed    
    
    
    
75. WILSON BH, Biga C, Marine JE
    Member Engagement Key to Transforming Cardiovascular Care for All.
    J Am Coll Cardiol. 2023;82:1967-1968.
    PubMed    
    
    
    
76. LAU ES, Di Achille P, Kopparapu K, Andrews CT, et al
    Deep Learning-Enabled Assessment of Left Heart Structure and Function Predicts Cardiovascular Outcomes.
    J Am Coll Cardiol. 2023;82:1936-1948.
    PubMed     Abstract available
    
    
    
77. REDFORS B, Stone GW, Alexander JH, Bates ER, et al
    Outcomes According to Coronary Revascularization Modality in the ISCHEMIA Trial.
    J Am Coll Cardiol. 2023 Nov 8:S0735-1097(23)07988.
    PubMed     Abstract available
    
    
    
78. SORENSEN NA, Guo L, Haller PM, Dehkordi F, et al
    Cardiac Troponin Assays to Distinguish Between Acute and Chronic Myocardial Injury.
    J Am Coll Cardiol. 2023;82:1885-1887.
    PubMed    
    
    
    
79. PLEIN S
    Comparative Accuracy of Noninvasive Imaging Tests in Stable Chest Pain: Does It Matter?
    J Am Coll Cardiol. 2023;82:1839-1841.
    PubMed    
    
    
    
80. ARAI AE, Schulz-Menger J, Shah DJ, Han Y, et al
    Stress Perfusion Cardiac Magnetic Resonance vs SPECT Imaging for Detection of Coronary Artery Disease.
    J Am Coll Cardiol. 2023;82:1828-1838.
    PubMed     Abstract available
    
    
    October 2023
81. GODOY LC, Farkouh ME, Ko DT
    Reply: Beta-Blockers in Stable Ischemic Heart Disease.
    J Am Coll Cardiol. 2023;82:e169.
    PubMed    
    
    
    
82. ZWECK E, Abohashem S, Kolte D
    Beta-Blockers in Stable Ischemic Heart Disease.
    J Am Coll Cardiol. 2023;82:e167.
    PubMed    
    
    
    
83. MONTALESCOT G, Granger C, Procopi N
    Lipid Lowering After Myocardial Infarction: Too Little, Too Late.
    J Am Coll Cardiol. 2023;82:1748-1750.
    PubMed    
    
    
    
84. DAVIS MB, Bello NA, Berlacher K, Harrington CM, et al
    Cardiovascular Fellowship Training in Cardio-Obstetrics: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;82:1792-1803.
    PubMed     Abstract available
    
    
    
85. MEHRAN R, Vogel B
    The Heart-Brain Connection in Myocardial Infarction in Women: A Dilemma to Tackle.
    J Am Coll Cardiol. 2023;82:1659-1661.
    PubMed    
    
    
    
86. HAUSVATER A, Spruill TM, Xia Y, Smilowitz NR, et al
    Psychosocial Factors of Women Presenting With Myocardial Infarction With or Without Obstructive Coronary Arteries.
    J Am Coll Cardiol. 2023;82:1649-1658.
    PubMed     Abstract available
    
    
    
87. JENTZER JC, van Diepen S
    The SCAI Shock Classification Has a New Home: The Cardiac Surgery Intensive Care Unit.
    J Am Coll Cardiol. 2023;82:1707-1710.
    PubMed    
    
    
    
88. ROESCHL T, Hinrichs N, Hommel M, Pfahringer B, et al
    Systematic Assessment of Shock Severity in Postoperative Cardiac Surgery Patients.
    J Am Coll Cardiol. 2023;82:1691-1706.
    PubMed     Abstract available
    
    
    
89. HULTEN EA, Weinberg RL, Keating FK
    Multiparametric Nuclear Stress Imaging: The Whole Is Greater Than the Sum of its Parts.
    J Am Coll Cardiol. 2023;82:1673-1675.
    PubMed    
    
    
    
90. PATEL KK, McGhie AI, Kennedy KF, Thompson RC, et al
    Impact of Positron Emission Tomographic Myocardial Perfusion Imaging on Patient Selection for Revascularization.
    J Am Coll Cardiol. 2023;82:1662-1672.
    PubMed     Abstract available
    
    
    
91. BAIREY MERZ CN, Gulati M, Wei J
    Understanding T2MI: Thank Goodness for the Women.
    J Am Coll Cardiol. 2023;82:1688-1690.
    PubMed    
    
    
    
92. YANG S, Kang J, Park KW, Hur SH, et al
    Comparison of Antiplatelet Monotherapies After Percutaneous Coronary Intervention According to Clinical, Ischemic, and Bleeding Risks.
    J Am Coll Cardiol. 2023;82:1565-1578.
    PubMed     Abstract available
    
    
    
93. MADDAHI J, Agostini D, Bateman TM, Bax JJ, et al
    Flurpiridaz F-18 PET Myocardial Perfusion Imaging in Patients With Suspected Coronary Artery Disease.
    J Am Coll Cardiol. 2023;82:1598-1610.
    PubMed     Abstract available
    
    
    
94. GYLDENKERNE C, Mortensen MB, Kahlert J, Thrane PG, et al
    10-Year Cardiovascular Risk in Patients With Newly Diagnosed Type 2 Diabetes Mellitus.
    J Am Coll Cardiol. 2023;82:1583-1594.
    PubMed     Abstract available
    
    
    
95. ORTEGA-PAZ L, Sabate M, Angiolillo DJ
    Long-Term Clopidogrel Monotherapy After Percutaneous Coronary Intervention: Will the Pupil Surpass the Master?
    J Am Coll Cardiol. 2023;82:1579-1582.
    PubMed    
    
    
    
96. BOURQUE JM
    Cardiac PET Perfusion Imaging: AURORA Lights the Way to a New Era.
    J Am Coll Cardiol. 2023;82:1611-1613.
    PubMed    
    
    
    
97. KANG DY, Ahn JM, Yun SC, Hur SH, et al
    Guiding Intervention for Complex Coronary Lesions by Optical Coherence Tomography or Intravascular Ultrasound.
    J Am Coll Cardiol. 2023 Oct 17:S0735-1097(23)07816.
    PubMed     Abstract available
    
    
    
98. GAUDINO M, Di Franco A, Arbustini E, Bacha E, et al
    Management of Adults With Anomalous Aortic Origin of the Coronary Arteries: State-of-the-Art Review.
    J Am Coll Cardiol. 2023 Oct 16:S0735-1097(23)06455.
    PubMed     Abstract available
    
    
    
99. MEDINA-INOJOSA JR, Somers VK, Garcia M, Thomas RJ, et al
    Performance of the ACC/AHA Pooled Cohort Cardiovascular Risk Equations in Clinical Practice.
    J Am Coll Cardiol. 2023;82:1499-1508.
    PubMed     Abstract available
    
    
    
100. GREGSON J, Stone GW, Bhatt DL, Packer M, et al
     Recurrent Events in Cardiovascular Trials: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2023;82:1445-1463.
     PubMed     Abstract available
     
     
     September 2023
101. FIGTREE GA, Vernon ST, Harmer JA, Gray MP, et al
     Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2023;82:1343-1359.
     PubMed     Abstract available
     
     
     
102. HUSSAIN J, Imsirovic H, Canney M, Clark EG, et al
     Impaired Renal Function and Major Cardiovascular Events in Young Adults.
     J Am Coll Cardiol. 2023;82:1316-1327.
     PubMed     Abstract available
     
     
     
103. DEVEREAUX PJ, Whitlock R, Lamy A
     Perioperative Myocardial Injury/Infarction After Cardiac Surgery: The Diagnostic Criteria Need to Change.
     J Am Coll Cardiol. 2023;82:1313-1315.
     PubMed    
     
     
     
104. DE COS-GANDOY A, Santos-Beneit G, Bodega P, Baxter J, et al
     Impact of Socioeconomic Background on Cardiovascular Health Promotion in Early Childhood.
     J Am Coll Cardiol. 2023;82:1377-1379.
     PubMed    
     
     
     
105. ALEGRIA JR, Wilson BH, Wright RS
     Ethics in Cardiovascular Care: A Call to Action.
     J Am Coll Cardiol. 2023;82:1373-1376.
     PubMed    
     
     
     
106. BLUMENTHAL RS, Grant J, Whelton SP
     Incidental Coronary Artery Calcium: Nothing Is More Expensive Than a Missed Opportunity.
     J Am Coll Cardiol. 2023;82:1203-1205.
     PubMed    
     
     
     
107. PENG AW, Dudum R, Jain SS, Maron DJ, et al
     Association of Coronary Artery Calcium Detected by Routine Ungated CT Imaging With Cardiovascular Outcomes.
     J Am Coll Cardiol. 2023;82:1192-1202.
     PubMed     Abstract available
     
     
     
108. LEOPOLD JA
     Complete Coronary Revascularization: A New Strategy to Improve Clinical Outcomes for Stable Coronary Artery Disease?
     J Am Coll Cardiol. 2023;82:1189-1191.
     PubMed    
     
     
     
109. SMILOWITZ NR, Prasad M, Widmer RJ, Toleva O, et al
     Comprehensive Management of ANOCA, Part 2-Program Development, Treatment, and Research Initiatives: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2023;82:1264-1279.
     PubMed     Abstract available
     
     
     
110. SAMUELS BA, Shah SM, Widmer RJ, Kobayashi Y, et al
     Comprehensive Management of ANOCA, Part 1-Definition, Patient Population, and Diagnosis: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2023;82:1245-1263.
     PubMed     Abstract available
     
     
     
111. STONE GW, Ali ZA, O'Brien SM, Rhodes G, et al
     Impact of Complete Revascularization in the ISCHEMIA Trial.
     J Am Coll Cardiol. 2023;82:1175-1188.
     PubMed     Abstract available
     
     
     
112. MCCARTHY CP, Murphy SP, Amponsah DK, Rambarat PK, et al
     Coronary Computed Tomographic Angiography With Fractional Flow Reserve in Patients With Type 2 Myocardial Infarction.
     J Am Coll Cardiol. 2023 Sep 18:S0735-1097(23)06469.
     PubMed     Abstract available
     
     
     
113. DAVID TE, Park J, Tatangelo M, Steve Fan CP, et al
     Cardiovascular Events After Aortic Root Repair in Patients With Marfan Syndrome.
     J Am Coll Cardiol. 2023;82:1068-1076.
     PubMed     Abstract available
     
     
     
114. THRANE PG, Olesen KKW, Thim T, Gyldenkerne C, et al
     Mortality Trends After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
     J Am Coll Cardiol. 2023;82:999-1010.
     PubMed     Abstract available
     
     
     
115. BARAN DA
     Cardiogenic Shock: Lessons From Hurricanes.
     J Am Coll Cardiol. 2023;82:996-998.
     PubMed    
     
     
     
116. STERLING LH, Fernando SM, Talarico R, Qureshi D, et al
     Long-Term Outcomes of Cardiogenic Shock Complicating Myocardial Infarction.
     J Am Coll Cardiol. 2023;82:985-995.
     PubMed     Abstract available
     
     
     
117. FANAROFF AC, Faggioni M
     Managing Myocardial Infarction in the Age of Multimorbidity.
     J Am Coll Cardiol. 2023;82:982-984.
     PubMed    
     
     
     
118. CHRISTENSEN DM, Strange JE, El-Chouli M, Falkentoft AC, et al
     Temporal Trends in Noncardiovascular Morbidity and Mortality Following Acute Myocardial Infarction.
     J Am Coll Cardiol. 2023;82:971-981.
     PubMed     Abstract available
     
     
     
119. HENRY TD, Baron SJ, Jacobs AK
     STEMI-Related Mortality: Don't Stop Believin'.
     J Am Coll Cardiol. 2023;82:1011-1013.
     PubMed    
     
     
     
120. PETEK BJ, Chung EH, Kim JH, Lampert R, et al
     Impact of Sex on Cardiovascular Adaptations to Exercise: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2023;82:1030-1038.
     PubMed     Abstract available
     
     
     August 2023
121. AN J, Zhang Y, Moran AE, Reynolds K, et al
     Reply: Understanding Myocardial Infarction in Young Individuals Now or in 30 Years?
     J Am Coll Cardiol. 2023;82:e77.
     PubMed    
     
     
     
122. ZEITOUNI M, Silvain J, Collet JP, Montalescot G, et al
     Understanding Myocardial Infarction in Young Individuals Now or in 30 Years?
     J Am Coll Cardiol. 2023;82:e75-e76.
     PubMed    
     
     
     
123. CHENG R, Azarbal B, Smith J
     Donor-Transmitted Coronary Artery Disease: Another Avenue to Expand Heart Transplantation?
     J Am Coll Cardiol. 2023;82:768-770.
     PubMed    
     
     
     
124. COUTO-MALLON D, Almenar-Bonet L, Barge-Caballero E, Hernandez-Perez FJ, et al
     Prevalence, Characteristics, and Prognostic Relevance of Donor-Transmitted Coronary Artery Disease in Heart Transplant Recipients.
     J Am Coll Cardiol. 2023;82:753-767.
     PubMed     Abstract available
     
     
     
125. DAUERMAN HL, Turco JV, Fuster V
     Artificial Intelligence, Bob Dylan, and Cardiovascular Scholarship.
     J Am Coll Cardiol. 2023;82:961-963.
     PubMed    
     
     
     
126. LAVIE CJ, German CA, Sanchis-Gomar F
     Reducing Mortality and Cardiovascular Disease: Stepping Up Our Game.
     J Am Coll Cardiol. 2023 Aug 28:S0735-1097(23)06401.
     PubMed    
     
     
     
127. STENS NA, Bakker EA, Manas A, Buffart LM, et al
     Relationship of Daily Step Counts to All-Cause Mortality and Cardiovascular Events.
     J Am Coll Cardiol. 2023 Aug 26:S0735-1097(23)06400.
     PubMed     Abstract available
     
     
     
128. MENDIETA G, Mehta S, Baber U, Angiolillo DJ, et al
     Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary Interventions.
     J Am Coll Cardiol. 2023;82:687-700.
     PubMed     Abstract available
     
     
     
129. BICCIRE FG, Haner J, Losdat S, Ueki Y, et al
     Concomitant Coronary Atheroma Regression and Stabilization in Response to Lipid-Lowering Therapy.
     J Am Coll Cardiol. 2023 Aug 20:S0735-1097(23)06468.
     PubMed     Abstract available
     
     
     
130. NELSON K, Fuster V, Ridker PM
     Low-Dose Colchicine for Secondary Prevention of Coronary Artery Disease: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2023;82:648-660.
     PubMed     Abstract available
     
     
     
131. SANDOVAL Y, Jaffe AS
     The Evolving Role of Cardiac Troponin: From Acute to Chronic Coronary Syndromes.
     J Am Coll Cardiol. 2023;82:486-488.
     PubMed    
     
     
     
132. WERESKI R, Adamson P, Shek Daud NS, McDermott M, et al
     High-Sensitivity Cardiac Troponin for Risk Assessment in Patients With Chronic Coronary Artery Disease.
     J Am Coll Cardiol. 2023;82:473-485.
     PubMed     Abstract available
     
     
     
133. BURGER PM, Koudstaal S, Mosterd A, Fiolet ATL, et al
     C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular Disease.
     J Am Coll Cardiol. 2023;82:414-426.
     PubMed     Abstract available
     
     
     
134. BEN-YEHUDA O
     Combination Therapy With Lower Statin Dose and the Race to LDL-C Goal: A Clear Winner?
     J Am Coll Cardiol. 2023;82:411-413.
     PubMed    
     
     
     
135. LEE SJ, Joo JH, Park S, Kim C, et al
     Combination Lipid-Lowering Therapy in Patients Undergoing Percutaneous Coronary Intervention.
     J Am Coll Cardiol. 2023;82:401-410.
     PubMed     Abstract available
     
     
     
136. SALIK JR, Zern EK, McCarthy IR, Theriot P, et al
     In-Person vs Virtual Interview Format for Fellowships in Cardiovascular Disease: A Nationwide Survey of Fellows-in-Training.
     J Am Coll Cardiol. 2023;82:465-468.
     PubMed    
     
     
     
137. JIALAL I, Ebong IA
     The Evolving Role of C-Reactive Protein in Heart Failure: Implications for Patients With Cardiovascular Disease.
     J Am Coll Cardiol. 2023;82:427-429.
     PubMed    
     
     
     July 2023
138. MARON MS, Mitten M, Borchers J, Rowin EJ, et al
     Medical and Legal Determinants of Sports Eligibility for Young Competitive Athletes With Cardiovascular Disease.
     J Am Coll Cardiol. 2023 Jul 27:S0735-1097(23)06030.
     PubMed    
     
     
     
139. FITZGIBBONS TP
     Epicardial Adipose-Derived miR92a-3p: Stress Reduction Therapy?
     J Am Coll Cardiol. 2023;82:333-335.
     PubMed    
     
     
     
140. AHMAD Y, Velazquez EJ
     The Interplay of Complete Revascularization and Angina: More Is More?
     J Am Coll Cardiol. 2023;82:314-316.
     PubMed    
     
     
     
141. MAVROMATIS K, Jones PG, Ali ZA, Stone GW, et al
     Complete Revascularization and Angina-Related Health Status in the ISCHEMIA Trial.
     J Am Coll Cardiol. 2023;82:295-313.
     PubMed     Abstract available
     
     
     
142. DEHMER GJ, Grines CL, Bakaeen FG, Beasley DL, et al
     2023 AHA/ACC Clinical Performance and Quality Measures for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures.
     J Am Coll Cardiol. 2023 Jul 21:S0735-1097(23)05187.
     PubMed    
     
     
     
143. WINCHESTER DE, Cibotti-Sun M
     2023 Chronic Coronary Disease Guideline-at-a-Glance.
     J Am Coll Cardiol. 2023 Jul 20:S0735-1097(23)05906.
     PubMed    
     
     
     
144. PETEK BJ, Al-Alusi MA, Moulson N, Grant AJ, et al
     Consumer Wearable Health and Fitness Technology in Cardiovascular Medicine: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2023;82:245-264.
     PubMed     Abstract available
     
     
     
145. VIRANI SS, Newby LK, Arnold SV, Bittner V, et al
     2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
     J Am Coll Cardiol. 2023 Jul 14:S0735-1097(23)05281.
     PubMed     Abstract available
     
     
     
146. MORALES J, Handelsman Y
     Cardiovascular Outcomes in Patients With Diabetes and Kidney Disease: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2023;82:161-170.
     PubMed     Abstract available
     
     
     
147. KUMBHANI DJ, de Lemos JA
     The Optimal Antiplatelet Agent for Secondary Prevention of Coronary Artery Disease: Ring Out the Old?
     J Am Coll Cardiol. 2023;82:106-108.
     PubMed    
     
     
     
148. GRAGNANO F, Cao D, Pirondini L, Franzone A, et al
     P2Y(12) Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events.
     J Am Coll Cardiol. 2023;82:89-105.
     PubMed     Abstract available
     
     
     
149. NAKASHIMA T, Otani T, Kato S, Arai M, et al
     Postprocedural Coronary Perfusion and Mortality in Patients With Acute Myocardial Infarction and Extracorporeal Cardiopulmonary Resuscitation.
     J Am Coll Cardiol. 2023;82:85-87.
     PubMed    
     
     
     
150. JAFFE AS, Body R, Mills NL, Aakre KM, et al
     Single Troponin Measurement to Rule Out Myocardial Infarction: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2023;82:60-69.
     PubMed     Abstract available
     
     
     
151. DRACHMAN DE, Gates CC, Linderbaum JA, Berlacher K, et al
     Evolving Cardiovascular Education in a Postpandemic World.
     J Am Coll Cardiol. 2023;82:82-84.
     PubMed    
     
     
     June 2023
152. DAUERMAN HL
     Primary PCI, Thrombus, and COVID-19: Remembrance of Things Past.
     J Am Coll Cardiol. 2023;81:2417-2419.
     PubMed    
     
     
     
153. RATHOD KS, Teoh Z, Tyrlis A, Choudry FA, et al
     Thrombus Burden and Outcomes in Patients With COVID-19 Presenting With STEMI Across the Pandemic.
     J Am Coll Cardiol. 2023;81:2406-2416.
     PubMed     Abstract available
     
     
     
154. BERG DD, Moura FA, Bellavia A, Scirica BM, et al
     Assessment of Atherothrombotic Risk in Patients With Type 2 Diabetes Mellitus.
     J Am Coll Cardiol. 2023;81:2391-2402.
     PubMed     Abstract available
     
     
     
155. WIVIOTT SD, Berg DD
     SGLT2 Inhibitors Reduce Heart Failure Hospitalization and Cardiovascular Death: Clarity and Consistency.
     J Am Coll Cardiol. 2023;81:2388-2390.
     PubMed    
     
     
     
156. USMAN MS, Siddiqi TJ, Anker SD, Bakris GL, et al
     Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations.
     J Am Coll Cardiol. 2023;81:2377-2387.
     PubMed     Abstract available
     
     
     
157. FORMAN DE, Kuchel GA, Newman JC, Kirkland JL, et al
     Impact of Geroscience on Therapeutic Strategies for Older Adults With Cardiovascular Disease: JACC Scientific Statement.
     J Am Coll Cardiol. 2023 Jun 21:S0735-1097(23)05782.
     PubMed     Abstract available
     
     
     
158. GODOY LC, Farkouh ME, Austin PC, Shah BR, et al
     Association of Beta-Blocker Therapy With Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease.
     J Am Coll Cardiol. 2023;81:2299-2311.
     PubMed     Abstract available
     
     
     
159. KUSUMOTO FM
     Cardiovascular Implantable Electronic Devices: Less Is (Often) More.
     J Am Coll Cardiol. 2023;81:2341-2343.
     PubMed    
     
     
     
160. DE GAETANO G, Costanzo S, Di Castelnuovo A
     Alcohol and Neural Network Activity: A New Link Between Alcohol in Moderation and Cardiovascular Health?
     J Am Coll Cardiol. 2023;81:2326-2327.
     PubMed    
     
     
     
161. MEZUE K, Osborne MT, Abohashem S, Zureigat H, et al
     Reduced Stress-Related Neural Network Activity Mediates the Effect of Alcohol on Cardiovascular Risk.
     J Am Coll Cardiol. 2023;81:2315-2325.
     PubMed     Abstract available
     
     
     
162. SUN J, Singh P, Shami A, Kluza E, et al
     Spatial Transcriptional Mapping Reveals Site-Specific Pathways Underlying Human Atherosclerotic Plaque Rupture.
     J Am Coll Cardiol. 2023;81:2213-2227.
     PubMed     Abstract available
     
     
     
163. STANTON AA
     Are We Sure We Know the Risk Factors for Cardiovascular Disease?
     J Am Coll Cardiol. 2023;81:2255-2257.
     PubMed    
     
     
     
164. RIST PM, Buring JE, Cook NR, Kurth T, et al
     Contribution of Migraine to Cardiovascular Disease Risk Prediction.
     J Am Coll Cardiol. 2023;81:2246-2254.
     PubMed     Abstract available
     
     
     
165. GRAGNANO F, Mehran R, Calabro P, Valgimigli M, et al
     Reply: DAPT Shortening After Complex PCI: Examining the Fine Print.
     J Am Coll Cardiol. 2023;81:e193.
     PubMed    
     
     
     
166. APOSTOLOS A, Vasilagkos G, Toutouzas K, Tsigkas G, et al
     DAPT Shortening After Complex PCI: Examining the Fine Print.
     J Am Coll Cardiol. 2023;81:e191.
     PubMed    
     
     
     
167. MA H, Jiang W, Guo L, Yin H, et al
     Mental Stress Testing in Women With Angina and No Obstructive Coronary Artery Disease.
     J Am Coll Cardiol. 2023;81:2210-2211.
     PubMed    
     
     
     
168. FRY ETA, Maddox TM, Bhatt AB
     Innovation in Cardiovascular Care Delivery.
     J Am Coll Cardiol. 2023;81:2207-2209.
     PubMed    
     
     
     May 2023
169. KAZI DS, DeJong C, Chen R, Wadhera RK, et al
     The Inflation Reduction Act and Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Disease.
     J Am Coll Cardiol. 2023;81:2103-2111.
     PubMed     Abstract available
     
     
     
170. GONG W, Yan Y, Montalescot G, Nie S, et al
     Reply: Uncovering Risk Factors for In-Hospital Cardiac Arrest in ST-Segment Elevation Myocardial Infarction.
     J Am Coll Cardiol. 2023;81:e173.
     PubMed    
     
     
     
171. KUNO T, Kohsaka S
     Uncovering Risk Factors for In-Hospital Cardiac Arrest in ST-Segment Elevation Myocardial Infarction.
     J Am Coll Cardiol. 2023;81:e171.
     PubMed    
     
     
     
172. MCCARTHY CP, Vyas A, Januzzi JL Jr
     What Is a Normal Troponin, Anyway?
     J Am Coll Cardiol. 2023;81:2040-2042.
     PubMed    
     
     
     
173. FUSTER JJ, Izzi B
     Clonal Hematopoiesis in Patients With Atherosclerotic Cardiovascular Disease: One Step Closer to the Clinical Scenario.
     J Am Coll Cardiol. 2023;81:2010-2012.
     PubMed    
     
     
     
174. GUMUSER ED, Schuermans A, Cho SMJ, Sporn ZA, et al
     Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.
     J Am Coll Cardiol. 2023;81:1996-2009.
     PubMed     Abstract available
     
     
     
175. WINCHESTER DE, Maron DJ, Blankstein R, Chang IC, et al
     ACC/AHA/ASE/ASNC/ASPC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2023 Multimodality Appropriate Use Criteria for the Detection and Risk Assessment of Chronic Coronary Disease.
     J Am Coll Cardiol. 2023 May 19:S0735-1097(23)05223.
     PubMed    
     
     
     
176. STONE GW, Gaudino M
     Reconsidering the Direction of Coronary Revascularization Trials.
     J Am Coll Cardiol. 2023;81:1974-1978.
     PubMed    
     
     
     
177. STOREY RF, Parker WAE
     Thrombotic Coronary Occlusion and Reperfusion: Unraveling the Determinants.
     J Am Coll Cardiol. 2023;81:1933-1936.
     PubMed    
     
     
     
178. KANJI R, Gue YX, Memtsas V, Spencer NH, et al
     Biomarkers of Thrombotic Status Predict Spontaneous Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction.
     J Am Coll Cardiol. 2023;81:1918-1932.
     PubMed     Abstract available
     
     
     
179. STONE GW, Kereiakes DJ, Gori T, Metzger DC, et al
     Five-Year Clinical Outcomes After Coronary Bioresorbable Scaffolds and Drug-Eluting Stents: The ABSORB IV Randomized Trial.
     J Am Coll Cardiol. 2023 May 13:S0735-1097(23)05527.
     PubMed     Abstract available
     
     
     
180. GULATI M, Holtzman JN, Kaur G
     Increased Rehospitalization in Young Women With Acute Myocardial Infarction at 1 Year: Adding Insult to Infarct.
     J Am Coll Cardiol. 2023;81:1807-1809.
     PubMed    
     
     
     
181. SAWANO M, Lu Y, Caraballo C, Mahajan S, et al
     Sex Difference in Outcomes of Acute Myocardial Infarction in Young Patients.
     J Am Coll Cardiol. 2023;81:1797-1806.
     PubMed     Abstract available
     
     
     
182. RADER DJ, Bajaj A
     Lipoprotein(a) and Oxidized Phospholipids: Partners in Crime or Individual Perpetrators in Cardiovascular Disease?
     J Am Coll Cardiol. 2023;81:1793-1796.
     PubMed    
     
     
     
183. GILLILAND TC, Liu Y, Mohebi R, Miksenas H, et al
     Lipoprotein(a), Oxidized Phospholipids, and Coronary Artery Disease Severity and Outcomes.
     J Am Coll Cardiol. 2023;81:1780-1792.
     PubMed     Abstract available
     
     
     
184. GOYAL P, Nanna MG
     Stable Coronary Artery Disease in the Age of Geriatric Cardiology.
     J Am Coll Cardiol. 2023;81:1710-1713.
     PubMed    
     
     
     
185. NGUYEN DD, Spertus JA, Alexander KP, Newman JD, et al
     Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease: The ISCHEMIA Trial.
     J Am Coll Cardiol. 2023;81:1697-1709.
     PubMed     Abstract available
     
     
     
186. MAQSOOD MH, Talha KM, Minhas AMK, Fudim M, et al
     CDC-WONDER Database Analysis of COVID-19 and Cardiovascular Disease-Related Mortality.
     J Am Coll Cardiol. 2023;81:1743-1745.
     PubMed    
     
     
     April 2023
187. SIMARD T, Vemulapalli S, Hibbert B, Alkhouli M, et al
     Reply: Mitral Valve Transcatheter Edge-to-Edge Repair in Patients With Cardiogenic Shock and Severe Mitral Regurgitation.
     J Am Coll Cardiol. 2023;81:e131.
     PubMed    
     
     
     
188. ELKARYONI A, Stone GW
     Mitral Valve Transcatheter Edge-to-Edge Repair in Patients With Cardiogenic Shock and Severe Mitral Regurgitation.
     J Am Coll Cardiol. 2023;81:e129.
     PubMed    
     
     
     
189. RODRIGUEZ F, Blumer V
     Cardiovascular Health in Hispanic/Latino Patients: From Research to Practice.
     J Am Coll Cardiol. 2023;81:1521-1523.
     PubMed    
     
     
     
190. PIRZADA A, Cai J, Heiss G, Sotres-Alvarez D, et al
     Evolving Science on Cardiovascular Disease Among Hispanic/Latino Adults: JACC International.
     J Am Coll Cardiol. 2023;81:1505-1520.
     PubMed     Abstract available
     
     
     
191. NARASIMMARAJ PR, Oseran A, Tale A, Xu J, et al
     Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Risk Factors Under the Inflation Reduction Act.
     J Am Coll Cardiol. 2023;81:1491-1501.
     PubMed     Abstract available
     
     
     
192. BRANDT EJ, Tobb K, Cambron JC, Ferdinand K, et al
     Assessing and Addressing Social Determinants of Cardiovascular Health: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2023;81:1368-1385.
     PubMed     Abstract available
     
     
     
193. BELMONT JW
     Genetic Epidemiology Highlights the Role of Aortic Strain and Distensibility in Cardiovascular Disease.
     J Am Coll Cardiol. 2023;81:1336-1338.
     PubMed    
     
     
     
194. STONE GW, Ali ZA
     Detection of Vulnerable Plaque With Intravascular Imaging: Case Closed.
     J Am Coll Cardiol. 2023;81:1231-1234.
     PubMed    
     
     
     
195. JIANG S, Fang C, Xu X, Xing L, et al
     Identification of High-Risk Coronary Lesions by 3-Vessel Optical Coherence Tomography.
     J Am Coll Cardiol. 2023;81:1217-1230.
     PubMed     Abstract available
     
     
     
196. YUN M, Bai Y, Nie B, Zhang X, et al
     Reply: Specific Brain-Heart Axis-Related Pathomechanism in Heart Failure Are Revealed Through Analysis of Cardiovascular Dynamics.
     J Am Coll Cardiol. 2023;81:e111.
     PubMed    
     
     
     
197. VALENZA G
     Specific Brain-Heart Axis-Related Pathomechanism in Heart Failure Are Revealed Through Analysis of Cardiovascular Dynamics.
     J Am Coll Cardiol. 2023;81:e109.
     PubMed    
     
     
     March 2023
198. TRUESDELL AG, Mehta A, Cilia LA
     Myocardial Infarction, Cardiogenic Shock, and Cardiac Arrest: Management Made Simple, But Not Too Simple.
     J Am Coll Cardiol. 2023;81:1177-1180.
     PubMed    
     
     
     
199. ZEYMER U, Alushi B, Noc M, Mamas MA, et al
     Influence of Culprit Lesion Intervention on Outcomes in Infarct-Related Cardiogenic Shock With Cardiac Arrest.
     J Am Coll Cardiol. 2023;81:1165-1176.
     PubMed     Abstract available
     
     
     
200. DOMANSKI MJ, Wu CO, Tian X, Hasan AA, et al
     Association of Incident Cardiovascular Disease With Time Course and Cumulative Exposure to Multiple Risk Factors.
     J Am Coll Cardiol. 2023;81:1151-1161.
     PubMed     Abstract available
     
     
     
201. LI J, Xin Y
     Air Pollution and Cardiovascular Diseases.
     J Am Coll Cardiol. 2023;81:e97.
     PubMed    
     
     
     
202. CAMILLI M, Russo M, Rinaldi R, Crea F, et al
     Reply: Air Pollution and Cardiovascular Diseases and Air Pollution and Rupture of Abdominal Aortic Aneurysms.
     J Am Coll Cardiol. 2023;81:e101.
     PubMed    
     
     
     
203. FUSTER V, Turco JV, Cortes-Canteli M
     Paradigm Shift: Cardiovascular Health in the Elderly-Beware of the Brain.
     J Am Coll Cardiol. 2023;81:1214-1215.
     PubMed    
     
     
     
204. VENTURA HO, Elagizi A, Lavie CJ
     Optimal Prevention of Cardiovascular Diseases: The Earlier the Better.
     J Am Coll Cardiol. 2023;81:1162-1164.
     PubMed    
     
     
     
205. KOKKINOS P, Faselis C, Samuel IBH, Lavie CJ, et al
     Changes in Cardiorespiratory Fitness and Survival in Patients With or Without Cardiovascular Disease.
     J Am Coll Cardiol. 2023;81:1137-1147.
     PubMed     Abstract available
     
     
     
206. FINOCCHIARO G, Radaelli D, D'Errico S, Papadakis M, et al
     Sudden Cardiac Death Among Adolescents in the United Kingdom.
     J Am Coll Cardiol. 2023;81:1007-1017.
     PubMed     Abstract available
     
     
     
207. DAWSON LP, Nehme E, Nehme Z, Davis E, et al
     Sex Differences in Epidemiology, Care, and Outcomes in Patients With Acute Chest Pain.
     J Am Coll Cardiol. 2023;81:933-945.
     PubMed     Abstract available
     
     
     
208. DANIAL P, Olivier ME, Brechot N, Ponnaiah M, et al
     Association Between Shock Etiology and 5-Year Outcomes After Venoarterial Extracorporeal Membrane Oxygenation.
     J Am Coll Cardiol. 2023;81:897-909.
     PubMed     Abstract available
     
     
     
209. PERIN EC, Borow KM, Henry TD, Mendelsohn FO, et al
     Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart Failure.
     J Am Coll Cardiol. 2023;81:849-863.
     PubMed     Abstract available
     
     
     
210. FRY ETA, Kuvin J, Sibley J
     Maintenance of Competence in Cardiovascular Practice: It's Time for More Learning, Less Testing.
     J Am Coll Cardiol. 2023;81:924-927.
     PubMed    
     
     
     
211. TAN N, Dey D, Marwick TH, Nerlekar N, et al
     Pericoronary Adipose Tissue as a Marker of Cardiovascular Risk: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2023;81:913-923.
     PubMed     Abstract available
     
     
     
212. HSU JC, Darden D, Du C, Marine JE, et al
     Initial Findings From the National Cardiovascular Data Registry of Atrial Fibrillation Ablation Procedures.
     J Am Coll Cardiol. 2023;81:867-878.
     PubMed     Abstract available
     
     
     February 2023
213. FUSTER V
     Editor-in-Chief's Top Picks From 2022.
     J Am Coll Cardiol. 2023;81:780-841.
     PubMed     Abstract available
     
     
     
214. TU S, Xu B, Chen L, Hong H, et al
     Short-Term Risk Stratification of Non-Flow-Limiting Coronary Stenosis by Angiographically Derived Radial Wall Strain.
     J Am Coll Cardiol. 2023;81:756-767.
     PubMed     Abstract available
     
     
     
215. SHIH E, Squiers JJ, Banwait JK, Mack MJ, et al
     Vein Graft Use and Long-Term Survival Following Coronary Bypass Grafting.
     J Am Coll Cardiol. 2023;81:713-725.
     PubMed     Abstract available
     
     
     
216. FUSTER V, Ibanez B
     Address Cardiovascular Health in Middle Age: Time to Remove the Blindfold.
     J Am Coll Cardiol. 2023;81:705-707.
     PubMed    
     
     
     
217. LLOYD-JONES DM, Wilkins JT
     Cardiovascular Risk Assessment and Prevention Across the Life Course: Propensity, Determinants, Risk, Disease.
     J Am Coll Cardiol. 2023;81:633-635.
     PubMed    
     
     
     
218. AN J, Zhang Y, Zhou H, Zhou M, et al
     Incidence of Atherosclerotic Cardiovascular Disease in Young Adults at Low Short-Term But High Long-Term Risk.
     J Am Coll Cardiol. 2023;81:623-632.
     PubMed     Abstract available
     
     
     
219. TRUESDELL AG, Alasnag MA, Kaul P, Rab ST, et al
     Intravascular Imaging During Percutaneous Coronary Intervention: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2023;81:590-605.
     PubMed     Abstract available
     
     
     
220. BHATT DL
     Optimal Antiplatelet Therapy Revisited: When Is a Single Better Than a Double?
     J Am Coll Cardiol. 2023;81:553-556.
     PubMed    
     
     
     
221. ZHU JZ, Manne-Goehler J, Agarwal A, Bahendeka SK, et al
     Medication Use for Cardiovascular Disease Prevention in 40 Low- and Middle-Income Countries.
     J Am Coll Cardiol. 2023;81:620-622.
     PubMed    
     
     
     
222. MENSAH GA, Vaduganathan M, Roth GA
     Acute Cardiovascular Complications of COVID-19: The High Risk of Underlying Heart Disease.
     J Am Coll Cardiol. 2023;81:570-573.
     PubMed    
     
     
     
223. GRAGNANO F, Mehran R, Branca M, Franzone A, et al
     P2Y(12) Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions.
     J Am Coll Cardiol. 2023;81:537-552.
     PubMed     Abstract available
     
     
     
224. BODEN WE, Marzilli M, Crea F, Mancini GBJ, et al
     Evolving Management Paradigm for Stable Ischemic Heart Disease Patients: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2023;81:505-514.
     PubMed     Abstract available
     
     
     
225. KERN KB
     Timely Reperfusion for Everyone...Except for Some Out-of-Hospital Cardiac Arrest Patients?
     J Am Coll Cardiol. 2023;81:457-459.
     PubMed    
     
     
     
226. SPIRITO A, Vaisnora L, Papadis A, Iacovelli F, et al
     Acute Coronary Occlusion in Patients With Non-ST-Segment Elevation Out-of-Hospital Cardiac Arrest.
     J Am Coll Cardiol. 2023;81:446-456.
     PubMed     Abstract available
     
     
     
227. BIANCHETTIN RG, Lavie CJ, Lopez-Jimenez F
     Challenges in Cardiovascular Evaluation and Management of Obese Patients: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2023;81:490-504.
     PubMed     Abstract available
     
     
     January 2023
228. COROVIC A, Wall C, Nus M, Gopalan D, et al
     Somatostatin Receptor PET/MR Imaging of Inflammation in Patients With Large Vessel Vasculitis and Atherosclerosis.
     J Am Coll Cardiol. 2023;81:336-354.
     PubMed     Abstract available
     
     
     
229. YONG C, Suvarna A, Harrington R, Gummidipundi S, et al
     Temporal Trends in Gender of Principal Investigators and Patients in Cardiovascular Clinical Trials.
     J Am Coll Cardiol. 2023;81:428-430.
     PubMed    
     
     
     
230. JIANG J, Chan L, Kauffman J, Narula J, et al
     Impact of Vaccination on Major Adverse Cardiovascular Events in Patients With COVID-19 Infection.
     J Am Coll Cardiol. 2023 Jan 27:S0735-1097(22)07601.
     PubMed     Abstract available
     
     
     
231. GULATI M, Berg DD
     High-Sensitivity Cardiac Troponin Assays in U.S. Hospitals: A Report Card.
     J Am Coll Cardiol. 2023;81:220-223.
     PubMed    
     
     
     
232. MCCARTHY C, Li S, Wang TY, Raber I, et al
     Implementation of High-Sensitivity Cardiac Troponin Assays in the United States.
     J Am Coll Cardiol. 2023;81:207-219.
     PubMed     Abstract available
     
     
     
233. SANDOVAL Y, Jaffe AS
     Type 2 Myocardial Infarction: Do We Need Risk Scores?
     J Am Coll Cardiol. 2023;81:169-171.
     PubMed    
     
     
     
234. TAGGART C, Monterrubio-Gomez K, Roos A, Boeddinghaus J, et al
     Improving Risk Stratification for Patients With Type 2 Myocardial Infarction.
     J Am Coll Cardiol. 2023;81:156-168.
     PubMed     Abstract available
     
     
     
235. BALLING M, Afzal S, Davey Smith G, Varbo A, et al
     Elevated LDL Triglycerides and Atherosclerotic Risk.
     J Am Coll Cardiol. 2023;81:136-152.
     PubMed     Abstract available
     
     
     
236. DUELL PB
     Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease Risk.
     J Am Coll Cardiol. 2023;81:153-155.
     PubMed    
     
     
     
237. TOPAZ M, Chorin E, Schwartz AL, Hochstadt A, et al
     Regional Antibiotic Delivery for Implanted Cardiovascular Electronic Device Infections.
     J Am Coll Cardiol. 2023;81:119-133.
     PubMed     Abstract available
     
     
     
238. FUSTER V
     Paradigm Shift: Children Present the Most Critical Point of Engagement for Choosing Cardiovascular Health.
     J Am Coll Cardiol. 2023;81:95-96.
     PubMed    
     
     
     
239. FARINA JM, Liblik K, Iomini P, Miranda-Arboleda AF, et al
     Infections and Cardiovascular Disease: JACC Focus Seminar 1/4.
     J Am Coll Cardiol. 2023;81:71-80.
     PubMed     Abstract available
     
     
     
240. KUMAR RK, Fuster V, Prabhakaran D
     Tropical Cardiovascular Diseases: The Forgotten Orphans.
     J Am Coll Cardiol. 2023;81:68-70.
     PubMed    
     
     
     December 2022
241. GORMAZ JG, Carrasco R
     Antioxidant Supplementation in Cardiovascular Prevention: New Challenges in the Face of New Evidence.
     J Am Coll Cardiol. 2022;80:2286-2288.
     PubMed    
     
     
     
242. AN P, Wan S, Luo Y, Luo J, et al
     Micronutrient Supplementation to Reduce Cardiovascular Risk.
     J Am Coll Cardiol. 2022;80:2269-2285.
     PubMed     Abstract available
     
     
     
243. MA H, Wang X, Li X, Heianza Y, et al
     Adding Salt to Foods and Risk of Cardiovascular Disease.
     J Am Coll Cardiol. 2022;80:2157-2167.
     PubMed     Abstract available
     
     
     
244. OPOTOWSKY AR, Allen KY, Bucholz EM, Burns KM, et al
     Pediatric and Congenital Cardiovascular Disease Research Challenges and Opportunities: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2022;80:2239-2250.
     PubMed     Abstract available
     
     
     
245. GHONEIM S
     Dietary Salt Intake Preferences and the Risk of Cardiovascular Disease.
     J Am Coll Cardiol. 2022;80:2168-2170.
     PubMed    
     
     
     November 2022
246. SONG L, Xu B, Tu S, Guan C, et al
     2-Year Outcomes of Angiographic Quantitative Flow Ratio-Guided Coronary Interventions.
     J Am Coll Cardiol. 2022;80:2089-2101.
     PubMed     Abstract available
     
     
     
247. DAVIDSON LJ, Cleveland JC, Welt FG, Anwaruddin S, et al
     A Practical Approach to Left Main Coronary Artery Disease: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;80:2119-2134.
     PubMed     Abstract available
     
     
     
248. ZAKAI NA, Minnier J, Safford MM, Koh I, et al
     Race-Dependent Association of High-Density Lipoprotein Cholesterol Levels With Incident Coronary Artery Disease.
     J Am Coll Cardiol. 2022;80:2104-2115.
     PubMed     Abstract available
     
     
     
249. FARKOUH ME, Mathew V
     Angiography-Based Measurement of Myocardial Ischemia: Will Simpler Be Better?
     J Am Coll Cardiol. 2022;80:2102-2103.
     PubMed    
     
     
     
250. LURZ P, Besler C
     Transcatheter Treatment of Mitral Regurgitation in Cardiogenic Shock: Promises and Pitfalls.
     J Am Coll Cardiol. 2022;80:2085-2088.
     PubMed    
     
     
     
251. IGLESIES-GRAU J, Fuster V, Fernandez-Jimenez R
     Reply: Carotid Plaque Burden Is a Stronger Predictor of Cardiovascular Risk Than IMT.
     J Am Coll Cardiol. 2022;80:e193.
     PubMed    
     
     
     
252. SPENCE JD
     Carotid Plaque Burden Is a Stronger Predictor of Cardiovascular Risk Than IMT.
     J Am Coll Cardiol. 2022;80:e191.
     PubMed    
     
     
     
253. IQBAL K, Kumar A, Rathore SS, Farid E, et al
     Gender and Racial/Ethnic Disparities in Award Distribution by Major Cardiovascular Societies From 2000 to 2021.
     J Am Coll Cardiol. 2022;80:2050-2053.
     PubMed    
     
     
     
254. HEDEGAARD BS, Bork CS, Kaltoft M, Klausen IC, et al
     Equivalent Impact of Elevated Lipoprotein(a) and Familial Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease.
     J Am Coll Cardiol. 2022;80:1998-2010.
     PubMed     Abstract available
     
     
     
255. WINTHER S, Schmidt SE, Foldyna B, Mayrhofer T, et al
     Coronary Calcium Scoring Improves Risk Prediction in Patients With Suspected Obstructive Coronary Artery Disease.
     J Am Coll Cardiol. 2022;80:1965-1977.
     PubMed     Abstract available
     
     
     
256. PAHUJA M, Johnson A, Kabir R, Bhogal S, et al
     Randomized Trials of Percutaneous Microaxial Flow Pump Devices: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;80:2028-2049.
     PubMed     Abstract available
     
     
     
257. KAPUR NK, Kanwar M, Sinha SS, Hernandez-Montfort J, et al
     Reply: "B" Is for Bad in SCAI Shock Staging: The Need for Early Diagnosis and Intervention.
     J Am Coll Cardiol. 2022;80:e183-e184.
     PubMed    
     
     
     
258. PATANE S, Patane F
     miRNAs and Criteria for Defining Stages of Cardiogenic Shock Severity.
     J Am Coll Cardiol. 2022;80:e181.
     PubMed    
     
     
     
259. MORICI N, Tavazzi G, Pappalardo F
     SCAI B Shock Stage: The Beginning and the End.
     J Am Coll Cardiol. 2022;80:e179.
     PubMed    
     
     
     
260. MAHFOUD F, Mancia G, Schmieder RE, Ruilope L, et al
     Cardiovascular Risk Reduction After Renal Denervation According to Time in Therapeutic Systolic Blood Pressure Range.
     J Am Coll Cardiol. 2022;80:1871-1880.
     PubMed     Abstract available
     
     
     
261. TARDIF JC, Thorin E
     Inhibition of the Mechanistic Target of Rapamycin in Acute Myocardial Infarction.
     J Am Coll Cardiol. 2022;80:1815-1817.
     PubMed    
     
     
     
262. GONG W, Yan Y, Wang X, Zheng W, et al
     Risk Factors for In-Hospital Cardiac Arrest in Patients With ST-Segment Elevation Myocardial Infarction.
     J Am Coll Cardiol. 2022;80:1788-1798.
     PubMed     Abstract available
     
     
     
263. ROZANSKI A, Miller RJH, Han D, Berman DS, et al
     Reply: Reconciling the Use of Myocardial Ischemia Testing for Selecting Patients for Coronary Revascularization.
     J Am Coll Cardiol. 2022;80:e171-e172.
     PubMed    
     
     
     
264. GAIBAZZI N, Foa A, Bergamaschi L, Tuttolomondo D, et al
     The War for the Best Therapy in Coronary Artery Disease Is Far From Being Won.
     J Am Coll Cardiol. 2022;80:e167.
     PubMed    
     
     
     
265. AL-KINDI S, Motairek I, Janus S, Deo S, et al
     Time-Varying Cardiovascular Effects of Finerenone in Diabetic Kidney Disease: Insights From FIDELIO-DKD and FIGARO-DKD Trials.
     J Am Coll Cardiol. 2022;80:1855-1856.
     PubMed    
     
     
     
266. FUSTER V, Turco JV
     Paradigm Shift to Address Cardiovascular Health at Every Stage.
     J Am Coll Cardiol. 2022;80:1848-1850.
     PubMed    
     
     
     
267. ROYSE A, Ren J, Royse C, Tian DH, et al
     Coronary Artery Bypass Surgery Without Saphenous Vein Grafting: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2022;80:1833-1843.
     PubMed     Abstract available
     
     
     
268. NICHOL G, West A
     Contemporary Approaches to Reducing Morbidity and Mortality in Patients With Acute Coronary Syndromes.
     J Am Coll Cardiol. 2022;80:1799-1801.
     PubMed    
     
     
     
269. RAJAGOPALAN S, Narula J
     The Perils of Anthropogenic Air Pollution: When All Roads Led to Rome.
     J Am Coll Cardiol. 2022;80:1829-1832.
     PubMed    
     
     
     
270. VADUGANATHAN M, Mensah GA, Turco JV, Fuster V, et al
     The Global Burden of Cardiovascular Diseases and Risk: A Compass for Future Health.
     J Am Coll Cardiol. 2022 Nov 8. pii: S0735-1097(22)07312.
     PubMed    
     
     
     
271. CARRENA O, Young R, Tarrar IH, Nelson AJ, et al
     Trends in the Incidence and Fatality of Peripercutaneous Coronary Intervention Stroke.
     J Am Coll Cardiol. 2022;80:1772-1774.
     PubMed    
     
     
     
272. OGUNNIYI MO, Mahmoud Z, Commodore-Mensah Y, Fleg JL, et al
     Eliminating Disparities in Cardiovascular Disease for Black Women: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2022;80:1762-1771.
     PubMed     Abstract available
     
     
     
273. BATRA G, Lindback J, Becker RC, Harrington RA, et al
     Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary Syndromes.
     J Am Coll Cardiol. 2022;80:1735-1747.
     PubMed     Abstract available
     
     
     
274. SARRAJU A, Bakris G, Cannon CP, Cherney D, et al
     Cardiovascular Effects of Canagliflozin in Relation to Renal Function and Albuminuria.
     J Am Coll Cardiol. 2022;80:1721-1731.
     PubMed     Abstract available
     
     
     
275. GRANDIN EW, Nunez JI, Kapur NK, Tonna J, et al
     Reply: Left Ventricular Mechanical Unloading During VA-ECMO: Not If, But Who and When?
     J Am Coll Cardiol. 2022;80:e157-e159.
     PubMed    
     
     
     
276. JORDE UP, Saeed O, Uehara M, Goldstein DJ, et al
     Left Ventricular Venting Based on Acute Shock ECMO Phenotype.
     J Am Coll Cardiol. 2022;80:e153-e154.
     PubMed    
     
     
     
277. CAPPANNOLI L, Sanna T, Burzotta F, Crea F, et al
     Who, When, and How to Vent During Venoarterial Extracorporeal Membrane Oxygenation?
     J Am Coll Cardiol. 2022;80:e149.
     PubMed    
     
     
     
278. KORJIAN S, Yeh RW, Cutlip DE
     Ischemic Risk Prediction Scores: Practice-Changing or Just Practice?
     J Am Coll Cardiol. 2022;80:1748-1750.
     PubMed    
     
     
     October 2022
279. DALEN M, Persson M, Glaser N, Sartipy U, et al
     Reply: Poverty and Adverse Outcomes Among Patients With Chronic Cardiovascular Disease: What Is the Mechanism?
     J Am Coll Cardiol. 2022;80:e141.
     PubMed    
     
     
     
280. PENDYAL A
     Poverty and Adverse Outcomes Among Patients With Chronic Cardiovascular Disease: What Is the Mechanism?
     J Am Coll Cardiol. 2022;80:e139.
     PubMed    
     
     
     
281. SALAH HM, Goldberg LR, Molinger J, Felker GM, et al
     Diaphragmatic Function in Cardiovascular Disease: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2022;80:1647-1659.
     PubMed     Abstract available
     
     
     
282. KALLIKOURDIS M, Condorelli G
     CD4(+) T Cell Subsets and Cardiovascular Disease in People With HIV.
     J Am Coll Cardiol. 2022;80:1645-1646.
     PubMed    
     
     
     
283. KUNDU S, Freiberg MS, Tracy RP, So-Armah KA, et al
     Circulating T Cells and Cardiovascular Risk in People With and Without HIV Infection.
     J Am Coll Cardiol. 2022;80:1633-1644.
     PubMed     Abstract available
     
     
     
284. PERSU A, Adlam D, Olin JW
     Spontaneous Coronary Artery Dissection: Lower Than Expected Recurrence Rate in a Large Prospective Canadian Cohort.
     J Am Coll Cardiol. 2022;80:1598-1600.
     PubMed    
     
     
     
285. SAW J, Starovoytov A, Aymong E, Inohara T, et al
     Canadian Spontaneous Coronary Artery Dissection Cohort Study: 3-Year Outcomes.
     J Am Coll Cardiol. 2022;80:1585-1597.
     PubMed     Abstract available
     
     
     
286. CLERKIN KJ, Topkara VK, Farr MA, Jain R, et al
     Noninvasive Physiologic Assessment of Cardiac Allograft Vasculopathy Is Prognostic for Post-Transplant Events.
     J Am Coll Cardiol. 2022;80:1617-1628.
     PubMed     Abstract available
     
     
     
287. BIRTCHER KK, Allen LA, Anderson JL, Bonaca MP, et al
     2022 ACC Expert Consensus Decision Pathway for Integrating Atherosclerotic Cardiovascular Disease and Multimorbidity Treatment: A Framework for Pragmatic, Patient-Centered Care: A Report of the American College of Cardiology Solution Set Oversight Com
     J Am Coll Cardiol. 2022 Oct 21. pii: S0735-1097(22)06670.
     PubMed    
     
     
     
288. SCHWARTZ GG, Szarek M, Zeiher A, White HD, et al
     Elevated C-Reactive Protein Amplifies Association of Lipoprotein(a) With Cardiovascular Risk and Clinical Benefit of Alirocumab.
     J Am Coll Cardiol. 2022 Oct 19. pii: S0735-1097(22)07027.
     PubMed    
     
     
     
289. BOHME M, Desch S, Rosolowski M, Scholz M, et al
     Impact of Clonal Hematopoiesis in Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction.
     J Am Coll Cardiol. 2022;80:1545-1556.
     PubMed     Abstract available
     
     
     
290. COLLET JP, Rahoual G, Hulot JS
     Clonal Hematopoiesis in Cardiogenic Shock: Beyond Conventional Prognostication?
     J Am Coll Cardiol. 2022;80:1557-1559.
     PubMed    
     
     
     
291. ABRAHAM S, Nohria A, Neilan TG, Asnani A, et al
     Cardiovascular Drug Interactions With Nirmatrelvir/Ritonavir in Patients With COVID-19: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2022 Oct 6. pii: S0735-1097(22)06825.
     PubMed     Abstract available
     
     
     
292. LACAZE P, Bakshi A, Riaz M, Polekhina G, et al
     Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes.
     J Am Coll Cardiol. 2022;80:1287-1298.
     PubMed     Abstract available
     
     
     September 2022
293. SMITS PC, Frigoli E, Vranckx P, Ozaki Y, et al
     Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk.
     J Am Coll Cardiol. 2022;80:1220-1237.
     PubMed     Abstract available
     
     
     
294. JIN Z, Xu B, Yang X, Jia R, et al
     Coronary Intervention Guided by Quantitative Flow Ratio vs Angiography in Patients With or Without Diabetes.
     J Am Coll Cardiol. 2022;80:1254-1264.
     PubMed     Abstract available
     
     
     
295. KERN MJ, Seto AH
     Does Diabetes Affect Angiographically Derived (QFR) Translesional Physiology?: Looking at the FAVOR III Diabetic Subset.
     J Am Coll Cardiol. 2022;80:1265-1267.
     PubMed    
     
     
     
296. KINLAY S
     Post-PCI Antithrombotic Treatment With High Bleeding Risk.
     J Am Coll Cardiol. 2022;80:1238-1240.
     PubMed    
     
     
     
297. LLOYD-JONES DM
     Cumulative Blood Pressure Measurement for Cardiovascular Disease Prediction: Promise and Pitfalls.
     J Am Coll Cardiol. 2022;80:1156-1158.
     PubMed    
     
     
     
298. WANG N, Harris K, Hamet P, Harrap S, et al
     Cumulative Systolic Blood Pressure Load and Cardiovascular Risk in Patients With Diabetes.
     J Am Coll Cardiol. 2022;80:1147-1155.
     PubMed     Abstract available
     
     
     
299. TUCKER WJ, Fegers-Wustrow I, Halle M, Haykowsky MJ, et al
     Exercise for Primary and Secondary Prevention of Cardiovascular Disease: JACC Focus Seminar 1/4.
     J Am Coll Cardiol. 2022;80:1091-1106.
     PubMed     Abstract available
     
     
     
300. KOVACIC JC, Fuster V
     Exercise, Cardiovascular Disease, and the Athlete's Heart.
     J Am Coll Cardiol. 2022;80:1088-1090.
     PubMed    
     
     
     
301. SIMARD T, Vemulapalli S, Jung RG, Vekstein A, et al
     Transcatheter Edge-to-Edge Repair in Patients with Severe Mitral Regurgitation and Cardiogenic Shock: TVT Registry Analysis.
     J Am Coll Cardiol. 2022 Sep 13. pii: S0735-1097(22)06767.
     PubMed     Abstract available
     
     
     
302. MINISSIAN MB, Mehta PK, Hayes SN, Park K, et al
     Ischemic Heart Disease in Young Women: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2022;80:1014-1022.
     PubMed     Abstract available
     
     
     
303. STAMATELOPOULOS K, Mueller-Hennessen M, Georgiopoulos G, Lopez-Ayala P, et al
     Cathepsin S Levels and Survival Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.
     J Am Coll Cardiol. 2022;80:998-1010.
     PubMed     Abstract available
     
     
     
304. BARNES GD
     RESPONSE: Learning to Implement Change in Cardiovascular Care.
     J Am Coll Cardiol. 2022;80:1026-1027.
     PubMed    
     
     
     
305. BHATT AS, Lee S, Vaduganathan M
     Building a Curriculum for the Cardiovascular Implementation Scientist.
     J Am Coll Cardiol. 2022;80:1023-1027.
     PubMed    
     
     
     
306. ANTONIADES C, Polkinghorne MD
     Novel Biomarkers for Risk Stratification in NSTE-ACS: Is There a Place for Cathepsin S?
     J Am Coll Cardiol. 2022;80:1011-1013.
     PubMed    
     
     
     August 2022
307. SANDHU RK, Dron JS, Liu Y, Moorthy MV, et al
     Polygenic Risk Score Predicts Sudden Death in Patients With Coronary Disease and Preserved Systolic Function.
     J Am Coll Cardiol. 2022;80:873-883.
     PubMed     Abstract available
     
     
     
308. TSIMIKAS S, Marcovina SM
     Ancestry, Lipoprotein(a), and Cardiovascular Risk Thresholds: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2022;80:934-946.
     PubMed     Abstract available
     
     
     
309. GOLDFARB M, De Hert M, Detraux J, Di Palo K, et al
     Severe Mental Illness and Cardiovascular Disease: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;80:918-933.
     PubMed     Abstract available
     
     
     
310. FAGUNDES A JR, Morrow DA, Oyama K, Furtado RHM, et al
     Biomarker Prediction of Complex Coronary Revascularization Procedures in the FOURIER Trial.
     J Am Coll Cardiol. 2022;80:887-897.
     PubMed     Abstract available
     
     
     
311. MONTALESCOT G, Guedeney P, Tijssen J
     A Multi-Biomarker Score for a Global Approach of Risk: Time for a Change?
     J Am Coll Cardiol. 2022;80:898-901.
     PubMed    
     
     
     
312. HERNESNIEMI JA
     Dawn of the Era of Individualized Genetic Profiling in the Prevention of Sudden Cardiac Death.
     J Am Coll Cardiol. 2022;80:884-886.
     PubMed    
     
     
     
313. ANDERSON HVS, Masri SC, Abdallah MS, Chang AM, et al
     2022 ACC/AHA Key Data Elements and Definitions for Chest Pain and Acute Myocardial Infarction: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Data Standards.
     J Am Coll Cardiol. 2022 Aug 26. pii: S0735-1097(22)05033.
     PubMed    
     
     
     
314. CAMILLI M, Russo M, Rinaldi R, Caffe A, et al
     Air Pollution and Coronary Vasomotor Disorders in Patients with Myocardial Ischemia and Non-Obstructive Coronary Arteries.
     J Am Coll Cardiol. 2022 Aug 25. pii: S0735-1097(22)06610.
     PubMed     Abstract available
     
     
     
315. STAHLI BE, Klingenberg R, Heg D, Branca M, et al
     Randomized Trial of Early mTOR Inhibition in Patients with Acute ST-Segment Elevation Myocardial Infarction.
     J Am Coll Cardiol. 2022 Aug 24. pii: S0735-1097(22)06613.
     PubMed     Abstract available
     
     
     
316. LLOYD-JONES DM, Morris PB, Ballantyne CM, Birtcher KK, et al
     2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committe
     J Am Coll Cardiol. 2022 Aug 23. pii: S0735-1097(22)05594.
     PubMed    
     
     
     
317. SEMSARIAN C, Gray B, Haugaa KH, Lampert R, et al
     Athletic Activity for Patients With Hypertrophic Cardiomyopathy and Other Inherited Cardiovascular Diseases: JACC Focus Seminar 3/4.
     J Am Coll Cardiol. 2022 Aug 19. pii: S0735-1097(22)05663.
     PubMed     Abstract available
     
     
     
318. ROTH GA, Vaduganathan M, Mensah GA
     Impact of the COVID-19 Pandemic on Cardiovascular Health in 2020: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;80:631-640.
     PubMed     Abstract available
     
     
     
319. KALOGEROPOULOS AP, Butler J
     Worsening Cardiovascular Disease Epidemiology in the United States: The Time for Preparation Is Now.
     J Am Coll Cardiol. 2022;80:579-583.
     PubMed    
     
     
     
320. MOHEBI R, Chen C, Ibrahim NE, McCarthy CP, et al
     Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates.
     J Am Coll Cardiol. 2022;80:565-578.
     PubMed     Abstract available
     
     
     
321. MARSIT O, Clavel MA, Paquin A, Deschenes V, et al
     Effects of Cyproheptadine on Mitral Valve Remodeling and Regurgitation After Myocardial Infarction.
     J Am Coll Cardiol. 2022;80:500-510.
     PubMed     Abstract available
     
     
     
322. PRIEST JR
     Leveraging Machine Learning for Translational Genetics of Cardiovascular Imaging.
     J Am Coll Cardiol. 2022;80:498-499.
     PubMed    
     
     
     
323. BEERI R
     Ischemic Mitral Regurgitation and Leaflet Remodeling: Another Arrow Hits the Target.
     J Am Coll Cardiol. 2022;80:511-512.
     PubMed    
     
     
     July 2022
324. VERMA KP, Inouye M, Meikle PJ, Nicholls SJ, et al
     New Cardiovascular Risk Assessment Techniques for Primary Prevention: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2022;80:373-387.
     PubMed     Abstract available
     
     
     
325. GIUSTINO G, Colombo A, Camaj A, Yasumura K, et al
     Coronary In-Stent Restenosis: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;80:348-372.
     PubMed     Abstract available
     
     
     
326. GOETTE A, Borof K, Breithardt G, Camm AJ, et al
     Presenting Pattern of Atrial Fibrillation and Outcomes of Early Rhythm Control Therapy.
     J Am Coll Cardiol. 2022;80:283-295.
     PubMed     Abstract available
     
     
     
327. EMDIN CA, Xia R, Agrawal S, Rana JS, et al
     Polygenic Score Assessed in Young Adulthood and Onset of Subclinical Atherosclerosis and Coronary Heart Disease.
     J Am Coll Cardiol. 2022;80:280-282.
     PubMed    
     
     
     
328. PAI RG, Vyas V
     Implications of Ethnicity in Subclinical Atherosclerosis in Underserved Populations: Inadequacy of Coronary Risk Score Models.
     J Am Coll Cardiol. 2022;80:230-232.
     PubMed    
     
     
     
329. AL-MALLAH MH, Dilsizian V
     The Impact of Revascularization on Mortality: A Debate on Patient Selection Bias vs Entry Bias.
     J Am Coll Cardiol. 2022;80:216-218.
     PubMed    
     
     
     
330. ROZANSKI A, Miller RJH, Gransar H, Han D, et al
     Benefit of Early Revascularization Based on Inducible Ischemia and Left Ventricular Ejection Fraction.
     J Am Coll Cardiol. 2022;80:202-215.
     PubMed     Abstract available
     
     
     
331. KOCHAR A, Smilowitz NR, Hochman JS
     Dynamic Cardiogenic Shock Classification: 2 Steps Forward, 1 Step Back.
     J Am Coll Cardiol. 2022;80:199-201.
     PubMed    
     
     
     
332. KAPUR NK, Kanwar M, Sinha SS, Thayer KL, et al
     Criteria for Defining Stages of Cardiogenic Shock Severity.
     J Am Coll Cardiol. 2022;80:185-198.
     PubMed     Abstract available
     
     
     
333. LAMONTE MJ, Manson JE, Anderson GL, Baker LD, et al
     Contributions of the Women's Health Initiative to Cardiovascular Research: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;80:256-275.
     PubMed     Abstract available
     
     
     
334. KOTTKE TE, Gupta AK, Thomas RJ
     Failing Cardiovascular Health: A Population Code Blue.
     J Am Coll Cardiol. 2022;80:152-154.
     PubMed    
     
     
     
335. GAO Y, Isakadze N, Duffy E, Sheng Q, et al
     Secular Trends in Risk Profiles Among Adults With Cardiovascular Disease in the United States.
     J Am Coll Cardiol. 2022;80:126-137.
     PubMed     Abstract available
     
     
     
336. ZHU JW, D'Angelo F, Miranda JJ, Yancy CW, et al
     Incorporating Cultural Competence and Cultural Humility in Cardiovascular Clinical Trials to Increase Diversity Among Participants.
     J Am Coll Cardiol. 2022;80:89-92.
     PubMed    
     
     
     
337. D'ANDREA E, Desai RJ, He M, Glynn RJ, et al
     Cardiovascular Risks of Hydroxychloroquine vs Methotrexate in Patients With Rheumatoid Arthritis.
     J Am Coll Cardiol. 2022;80:36-46.
     PubMed     Abstract available
     
     
     
338. YU AF, Steingart RM
     ARIC Welcomes Cancer Survivors Into Their Communities: Unraveling the Link Between Cancer and Cardiovascular Disease.
     J Am Coll Cardiol. 2022;80:33-35.
     PubMed    
     
     
     
339. FLORIDO R, Daya NR, Ndumele CE, Koton S, et al
     Cardiovascular Disease Risk Among Cancer Survivors: The Atherosclerosis Risk In Communities (ARIC) Study.
     J Am Coll Cardiol. 2022;80:22-32.
     PubMed     Abstract available
     
     
     
340. LUNARDI M, Louvard Y, Lefevre T, Stankovic G, et al
     Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations.
     J Am Coll Cardiol. 2022;80:63-88.
     PubMed     Abstract available
     
     
     June 2022
341. MENDES LA, Weissman G, Berlacher K, Damp JB, et al
     Competency-Based Alternative Training Pathway in Cardiovascular Disease and Clinical Cardiac Electrophysiology.
     J Am Coll Cardiol. 2022;79:2540-2542.
     PubMed    
     
     
     
342. PRASADA S, Desai MY, Saad M, Smilowitz NR, et al
     Preoperative Atrial Fibrillation and Cardiovascular Outcomes After Noncardiac Surgery.
     J Am Coll Cardiol. 2022;79:2471-2485.
     PubMed     Abstract available
     
     
     
343. BOZKURT B, Das SR, Addison D, Gupta A, et al
     2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards.
     J Am Coll Cardiol. 2022 Jun 22. pii: S0735-1097(22)04579.
     PubMed    
     
     
     
344. MEHTA A, Vasquez N, Joshi PH
     Reply: Accuracy Transcends Simplicity in Coronary Atherosclerosis Imaging.
     J Am Coll Cardiol. 2022;79:e489.
     PubMed    
     
     
     
345. NURMOHAMED NS, Tromp TR, Kaiser Y, Bom MJ, et al
     Accuracy Transcends Simplicity in Coronary Atherosclerosis Imaging.
     J Am Coll Cardiol. 2022;79:e487.
     PubMed    
     
     
     
346. RALLIDIS LS, Xenogiannis I, Brilakis ES, Bhatt DL, et al
     Causes, Angiographic Characteristics, and Management of Premature Myocardial Infarction: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;79:2431-2449.
     PubMed     Abstract available
     
     
     
347. WILSON PWF, Remaley AT
     Ischemic Heart Disease Risk and Remnant Cholesterol Levels.
     J Am Coll Cardiol. 2022;79:2398-2400.
     PubMed    
     
     
     
348. DOI T, Langsted A, Nordestgaard BG
     Elevated Remnant Cholesterol Reclassifies Risk of Ischemic Heart Disease and Myocardial Infarction.
     J Am Coll Cardiol. 2022;79:2383-2397.
     PubMed     Abstract available
     
     
     
349. BELTRAME JF, Tavella R, Zeitz CJ
     Beyond Structural Angiography: The Emergence of Functional Coronary Angiography.
     J Am Coll Cardiol. 2022;79:2379-2382.
     PubMed    
     
     
     
350. TAKAHASHI T, Samuels BA, Li W, Parikh MA, et al
     Safety of Provocative Testing With Intracoronary Acetylcholine and Implications for Standard Protocols.
     J Am Coll Cardiol. 2022;79:2367-2378.
     PubMed     Abstract available
     
     
     
351. CHOU JC
     Hypertensive Disorders of Pregnancy and Cardiovascular Risk: We Are Missing the Opportunity of a Lifetime.
     J Am Coll Cardiol. 2022;79:2412-2414.
     PubMed    
     
     
     
352. LEVINE LD, Ky B, Chirinos JA, Koshinksi J, et al
     Prospective Evaluation of Cardiovascular Risk 10 Years After a Hypertensive Disorder of Pregnancy.
     J Am Coll Cardiol. 2022;79:2401-2411.
     PubMed     Abstract available
     
     
     
353. HONIGBERG MC, Jowell AR
     Accelerated Coronary Atherosclerosis After Preeclampsia: Seeing Is Believing.
     J Am Coll Cardiol. 2022;79:2322-2324.
     PubMed    
     
     
     
354. HAUGE MG, Damm P, Kofoed KF, Ersboll AS, et al
     Early Coronary Atherosclerosis in Women With Previous Preeclampsia.
     J Am Coll Cardiol. 2022;79:2310-2321.
     PubMed     Abstract available
     
     
     
355. VERDOIA M, Gioscia R, Rognoni A
     Updates on the Management of STEMI in 2021: Beyond COVID-19.
     J Am Coll Cardiol. 2022;79:2245-2246.
     PubMed    
     
     
     
356. GARCIA S, Dehghani P, Stanberry L, Grines C, et al
     Trends in Clinical Presentation, Management, and Outcomes of STEMI in Patients With COVID-19.
     J Am Coll Cardiol. 2022;79:2236-2244.
     PubMed     Abstract available
     
     
     May 2022
357. ZHAO Y, Lu X, Wan F, Gao L, et al
     Disruption of Circadian Rhythms by Shift Work Exacerbates Reperfusion Injury in Myocardial Infarction.
     J Am Coll Cardiol. 2022;79:2097-2115.
     PubMed     Abstract available
     
     
     
358. RAJKUMAR CA, Wereski R, Parsonage W, Cullen L, et al
     Association Between High-Sensitivity Cardiac Troponin, Myocardial Ischemia, and Revascularization in Stable Coronary Artery Disease.
     J Am Coll Cardiol. 2022;79:2185-2187.
     PubMed    
     
     
     
359. OLIVEROS E, Burgess S, Nadella N, Davidson L, et al
     Becoming a Parent During Cardiovascular Training.
     J Am Coll Cardiol. 2022;79:2119-2126.
     PubMed     Abstract available
     
     
     
360. SWIRSKI FK, McAlpine CS
     Circadian Cadence and NR1D1 Tune Cardiovascular Disease.
     J Am Coll Cardiol. 2022;79:2116-2118.
     PubMed    
     
     
     
361. HOLMES KW, Markwardt S, Eagle KA, Devereux RB, et al
     Cardiovascular Outcomes in Aortopathy: GenTAC Registry of Genetically Triggered Aortic Aneurysms and Related Conditions.
     J Am Coll Cardiol. 2022;79:2069-2081.
     PubMed     Abstract available
     
     
     
362. ARCARI L, Nunez Gil IJ, Stiermaier T, El-Battrawy I, et al
     Gender Differences in Takotsubo Syndrome.
     J Am Coll Cardiol. 2022;79:2085-2093.
     PubMed     Abstract available
     
     
     
363. UDELL JA, Jones WS, Petrie MC, Harrington J, et al
     Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2022;79:2058-2068.
     PubMed     Abstract available
     
     
     
364. SCHOCKEN DD
     Registry Evidence for Modulation of the Acute Ischemic Heart Disease Pathway: Statins Prevent Heart Failure?
     J Am Coll Cardiol. 2022;79:2034-2036.
     PubMed    
     
     
     
365. BUGIARDINI R, Yoon J, Mendieta G, Kedev S, et al
     Reduced Heart Failure and Mortality in Patients Receiving Statin Therapy Before Initial Acute Coronary Syndrome.
     J Am Coll Cardiol. 2022;79:2021-2033.
     PubMed     Abstract available
     
     
     
366. NICOLAIDES AN, Panayiotou AG, Griffin M, Tyllis T, et al
     Arterial Ultrasound Testing to Predict Atherosclerotic Cardiovascular Events.
     J Am Coll Cardiol. 2022;79:1969-1982.
     PubMed     Abstract available
     
     
     
367. THANGAM M, Nazif TM, Parke M, Kandzari DE, et al
     Timing of Stent Thrombosis After 1-Month Discontinuation of Dual Antiplatelet Therapy.
     J Am Coll Cardiol. 2022;79:1963-1965.
     PubMed    
     
     
     
368. VANDENBRIELE C, Arachchillage DJ, Frederiks P, Giustino G, et al
     Anticoagulation for Percutaneous Ventricular Assist Device-Supported Cardiogenic Shock: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2022;79:1949-1962.
     PubMed     Abstract available
     
     
     
369. THOMAS GS, Wong ND
     Detecting Coronary Calcium in Young Adults: Are We There Yet?
     J Am Coll Cardiol. 2022;79:1887-1889.
     PubMed    
     
     
     
370. JAVAID A, Dardari ZA, Mitchell JD, Whelton SP, et al
     Distribution of Coronary Artery Calcium by Age, Sex, and Race Among Patients 30-45 Years Old.
     J Am Coll Cardiol. 2022;79:1873-1886.
     PubMed     Abstract available
     
     
     
371. SHARMA G, Ipek EG, Grandi SM
     The Impact of Hypertensive Disorders of Pregnancy on Cardiovascular Outcomes: Flying Under the Radar.
     J Am Coll Cardiol. 2022;79:1914-1916.
     PubMed    
     
     
     
372. STUART JJ, Tanz LJ, Rimm EB, Spiegelman D, et al
     Cardiovascular Risk Factors Mediate the Long-Term Maternal Risk Associated With Hypertensive Disorders of Pregnancy.
     J Am Coll Cardiol. 2022;79:1901-1913.
     PubMed     Abstract available
     
     
     
373. COLANTONIO LD, Wang Z, Chen L, Mejia R, et al
     Trends in High-Intensity Statin Therapy After Myocardial Infarction Among U.S. Adults, 2011-2019.
     J Am Coll Cardiol. 2022;79:1870-1872.
     PubMed    
     
     
     
374. KELSEY MD, Nelson AJ, Green JB, Granger CB, et al
     Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: JACC Guideline Comparison.
     J Am Coll Cardiol. 2022;79:1849-1857.
     PubMed     Abstract available
     
     
     
375. GABA P, Bhatt DL, Steg PG, Miller M, et al
     Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction.
     J Am Coll Cardiol. 2022;79:1660-1671.
     PubMed     Abstract available
     
     
     
376. BEHAN SA, Mulder H, Rockhold FW, Gutierrez JA, et al
     Impact of Polyvascular Disease and Diabetes on Limb and Cardiovascular Risk in Peripheral Artery Disease.
     J Am Coll Cardiol. 2022;79:1781-1783.
     PubMed    
     
     
     
377. SPERTUS JA, Mack MJ, Ohman EM
     Improving the National Cardiovascular Data Registry's Value to Elevate the Quality of Cardiovascular Care.
     J Am Coll Cardiol. 2022;79:1713-1716.
     PubMed    
     
     
     
378. MALENKA DJ, Bhatt DL, Bradley SM, Shahian DM, et al
     The National Cardiovascular Data Registry Data Quality Program 2020: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;79:1704-1712.
     PubMed     Abstract available
     
     
     
379. GONZALEZ-JARAMILLO N, Wilhelm M, Arango-Rivas AM, Gonzalez-Jaramillo V, et al
     Systematic Review of Physical Activity Trajectories and Mortality in Patients With Coronary Artery Disease.
     J Am Coll Cardiol. 2022;79:1690-1700.
     PubMed     Abstract available
     
     
     
380. LEE HH, Lee H, Townsend RR, Kim DW, et al
     Cardiovascular Implications of the 2021 KDIGO Blood Pressure Guideline for Adults With Chronic Kidney Disease.
     J Am Coll Cardiol. 2022;79:1675-1686.
     PubMed     Abstract available
     
     
     
381. BODEN WE, Andersson C
     Optimizing Dyslipidemic Cardiovascular Residual Risk Reduction With Icosapent Ethyl in Post-MI Patients.
     J Am Coll Cardiol. 2022;79:1672-1674.
     PubMed    
     
     
     April 2022
382. GRANGER CB, Krychtiuk KA, Gersh BJ
     Personalizing Choice of CABG vs PCI for Multivessel Disease: Predictive Model Falls Short.
     J Am Coll Cardiol. 2022;79:1474-1476.
     PubMed    
     
     
     
383. TAKAHASHI K, Serruys PW, Fuster V, Farkouh ME, et al
     External Validation of the FREEDOM Score for Individualized Decision Making Between CABG and PCI.
     J Am Coll Cardiol. 2022;79:1458-1473.
     PubMed     Abstract available
     
     
     
384. ARENAL A, Avila P, Jimenez-Candil J, Tercedor L, et al
     Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.
     J Am Coll Cardiol. 2022;79:1441-1453.
     PubMed     Abstract available
     
     
     
385. MENTIAS A, Aminian A, Youssef D, Pandey A, et al
     Long-Term Cardiovascular Outcomes After Bariatric Surgery in the Medicare Population.
     J Am Coll Cardiol. 2022;79:1429-1437.
     PubMed     Abstract available
     
     
     
386. REGENSTEINER JG, Reusch JEB
     Sex Differences in Cardiovascular Consequences of Hypertension, Obesity, and Diabetes: JACC Focus Seminar 4/7.
     J Am Coll Cardiol. 2022;79:1492-1505.
     PubMed     Abstract available
     
     
     
387. POWELL-WILEY TM, Osei Baah F, Thompson K
     Bariatric Surgery and Cardiovascular Outcomes: What Can We Learn From More Representative Cohorts?
     J Am Coll Cardiol. 2022;79:1438-1440.
     PubMed    
     
     
     
388. SOLOLA NUSSBAUM S, Henry S, Yong CM, Daugherty SL, et al
     Sex-Specific Considerations in the Presentation, Diagnosis, and Management of Ischemic Heart Disease: JACC Focus Seminar 2/7.
     J Am Coll Cardiol. 2022;79:1398-1406.
     PubMed     Abstract available
     
     
     
389. GAUDINO M, Di Franco A, Cao D, Giustino G, et al
     Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery Disease: JACC Focus Seminar 3/7.
     J Am Coll Cardiol. 2022;79:1407-1425.
     PubMed     Abstract available
     
     
     
390. CLAYTON JA, Gaugh MD
     Sex as a Biological Variable in Cardiovascular Diseases: JACC Focus Seminar 1/7.
     J Am Coll Cardiol. 2022;79:1388-1397.
     PubMed     Abstract available
     
     
     
391. MENSAH GA, Fuster V
     Sex and Gender Differences in Cardiovascular Health.
     J Am Coll Cardiol. 2022;79:1385-1387.
     PubMed    
     
     
     
392. MIHATOV N, Mosarla RC, Kirtane AJ, Parikh SA, et al
     Outcomes Associated With Peripheral Artery Disease in Myocardial Infarction With Cardiogenic Shock.
     J Am Coll Cardiol. 2022;79:1223-1235.
     PubMed     Abstract available
     
     
     
393. FEGERS-WUSTROW I, Gianos E, Halle M, Yang E, et al
     Comparison of American and European Guidelines for Primary Prevention of Cardiovascular Disease: JACC Guideline Comparison.
     J Am Coll Cardiol. 2022;79:1304-1313.
     PubMed     Abstract available
     
     
     
394. KIM TO, Kang DY, Ahn JM, Kim SO, et al
     Prognostic Impact of Mildly Impaired Renal Function in Patients Undergoing Multivessel Coronary Revascularization.
     J Am Coll Cardiol. 2022;79:1270-1284.
     PubMed     Abstract available
     
     
     
395. MEHRAN R, Cao D, Vogel B
     Rethinking the Role of Impaired Renal Function in Multivessel PCI or CABG.
     J Am Coll Cardiol. 2022;79:1285-1287.
     PubMed    
     
     
     
396. GRANDIN EW, Nunez JI, Willar B, Kennedy K, et al
     Mechanical Left Ventricular Unloading in Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation.
     J Am Coll Cardiol. 2022;79:1239-1250.
     PubMed     Abstract available
     
     
     March 2022
397. POWER DA, Lampert J, Camaj A, Bienstock SW, et al
     Cardiovascular Complications of Interatrial Conduction Block: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;79:1199-1211.
     PubMed     Abstract available
     
     
     
398. KONSTAM MA
     The Cardiovascular Pharmaceutical Cornucopia: A Conundrum of Riches.
     J Am Coll Cardiol. 2022;79:1138-1140.
     PubMed    
     
     
     
399. NASIR K, DeFilippis A
     Big Data and ASCVD Risk Prediction: Building a Better Mouse Trap?
     J Am Coll Cardiol. 2022;79:1167-1169.
     PubMed    
     
     
     
400. PETRAZZINI BO, Chaudhary K, Marquez-Luna C, Forrest IS, et al
     Coronary Risk Estimation Based on Clinical Data in Electronic Health Records.
     J Am Coll Cardiol. 2022;79:1155-1166.
     PubMed     Abstract available
     
     
     
401. SERAPHIM A, Dowsing B, Rathod KS, Shiwani H, et al
     Quantitative Myocardial Perfusion Predicts Outcomes in Patients With Prior Surgical Revascularization.
     J Am Coll Cardiol. 2022;79:1141-1151.
     PubMed     Abstract available
     
     
     
402. WONG CCY, Yong ASC, Keech A, Ada C, et al
     Evolution of the Coronary Microcirculation After Restoration of Epicardial Blood Flow in STEMI.
     J Am Coll Cardiol. 2022;79:1127-1128.
     PubMed    
     
     
     
403. CAMAJ A, Fuster V, Giustino G, Bienstock SW, et al
     Left Ventricular Thrombus Following Acute Myocardial Infarction: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;79:1010-1022.
     PubMed     Abstract available
     
     
     
404. DAVIES JE
     iFR-SWEDEHEART: Answering the Questions of a Decade of Scientific Debate About iFR and FFR.
     J Am Coll Cardiol. 2022;79:975-976.
     PubMed    
     
     
     
405. GOTBERG M, Berntorp K, Rylance R, Christiansen EH, et al
     5-Year Outcomes of PCI Guided by Measurement of Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve.
     J Am Coll Cardiol. 2022;79:965-974.
     PubMed     Abstract available
     
     
     
406. GLUCKMAN TJ, Bhave NM, Allen LA, Chung EH, et al
     2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play: A Report of the American College of Cardiology
     J Am Coll Cardiol. 2022 Mar 14. pii: S0735-1097(22)00306.
     PubMed    
     
     
     
407. DOUGLAS PS, Mack MJ, Acosta DA, Benjamin EJ, et al
     2022 ACC Health Policy Statement on Building Respect, Civility, and Inclusion in the Cardiovascular Workplace: A Report of the American College of Cardiology Solution Set Oversight Committee.
     J Am Coll Cardiol. 2022 Mar 12. pii: S0735-1097(22)00585.
     PubMed    
     
     
     
408. JANUZZI JL JR, Ohman EM
     Underdiagnosis of Ischemic Heart Disease in New-Onset Heart Failure: A Call to Action.
     J Am Coll Cardiol. 2022;79:861-863.
     PubMed    
     
     
     
409. WALSH MN
     Gender Diversity in Cardiovascular Clinical Trial Research Begins at the Top.
     J Am Coll Cardiol. 2022;79:929-932.
     PubMed    
     
     
     
410. ZHENG J, Heidenreich PA, Kohsaka S, Fearon WF, et al
     Variability in Coronary Artery Disease Testing for Patients With New-Onset Heart Failure.
     J Am Coll Cardiol. 2022;79:849-860.
     PubMed     Abstract available
     
     
     
411. LIBERALE L, Badimon L, Montecucco F, Luscher TF, et al
     Inflammation, Aging, and Cardiovascular Disease: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2022;79:837-847.
     PubMed     Abstract available
     
     
     
412. STONE NJ, Smith SC Jr, Orringer CE, Rigotti NA, et al
     Managing Atherosclerotic Cardiovascular Risk in Young Adults: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;79:819-836.
     PubMed     Abstract available
     
     
     
413. MEHTA A, Vasquez N, Ayers CR, Patel J, et al
     Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk.
     J Am Coll Cardiol. 2022;79:757-768.
     PubMed     Abstract available
     
     
     February 2022
414. SUN Y, Pinto C, Camus S, Duval V, et al
     Splenic Marginal Zone B Lymphocytes Regulate Cardiac Remodeling After Acute Myocardial Infarction in Mice.
     J Am Coll Cardiol. 2022;79:632-647.
     PubMed     Abstract available
     
     
     
415. KAYANI WT, Khalid U, Alam M
     Predicting Left Main Coronary Artery Stenosis Without Imaging: Are We There Yet?
     J Am Coll Cardiol. 2022;79:662-664.
     PubMed    
     
     
     
416. SENIOR R, Reynolds HR, Min JK, Berman DS, et al
     Predictors of Left Main Coronary Artery Disease in the ISCHEMIA Trial.
     J Am Coll Cardiol. 2022;79:651-661.
     PubMed     Abstract available
     
     
     
417. KOVACIC JC, Bosca L
     Immuno-Modulation to Treat Common Cardiovascular Diseases: Moving From Sledgehammer to Precision Therapeutics.
     J Am Coll Cardiol. 2022;79:648-650.
     PubMed    
     
     
     
418. TRINDER M, Paruchuri K, Haidermota S, Bernardo R, et al
     Repeat Measures of Lipoprotein(a) Molar Concentration and Cardiovascular Risk.
     J Am Coll Cardiol. 2022;79:617-628.
     PubMed     Abstract available
     
     
     
419. MARCOVINA SM, Shapiro MD
     Measurement of Lipoprotein(a): A Once in a Lifetime Opportunity.
     J Am Coll Cardiol. 2022;79:629-631.
     PubMed    
     
     
     
420. UEKI Y, Otsuka T, Bar S, Koskinas KC, et al
     Frequency and Outcomes of Periprocedural MI in Patients With Chronic Coronary Syndromes Undergoing PCI.
     J Am Coll Cardiol. 2022;79:513-526.
     PubMed     Abstract available
     
     
     
421. MCCARTHY CP, Januzzi JL Jr
     Periprocedural MI as an Endpoint in Clinical Trials: A Proposed Path Forward.
     J Am Coll Cardiol. 2022;79:527-529.
     PubMed    
     
     
     
422. TIJSSEN A, Jorstad HT, Minneboo M, Ter Riet G, et al
     Long-Term Effects of Community-Based Lifestyle Interventions in Coronary Patients: RESPONSE-2 3-Year Follow-Up.
     J Am Coll Cardiol. 2022;79:511-512.
     PubMed    
     
     
     
423. IJAZ N, Buta B, Xue QL, Mohess DT, et al
     Interventions for Frailty Among Older Adults With Cardiovascular Disease: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;79:482-503.
     PubMed     Abstract available
     
     
     
424. VADUGANATHAN M, Sattar N, Xu J, Butler J, et al
     Stress Cardiac Biomarkers, Cardiovascular and Renal Outcomes, and Response to Canagliflozin.
     J Am Coll Cardiol. 2022;79:432-444.
     PubMed     Abstract available
     
     
     
425. HARSKAMP RE, Fanaroff AC, Lopes RD, Wojdyla DM, et al
     Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention.
     J Am Coll Cardiol. 2022;79:417-427.
     PubMed     Abstract available
     
     
     
426. CHA JJ, Bae S, Park DW, Park JH, et al
     Clinical Outcomes in Patients With Delayed Hospitalization for Non-ST-Segment Elevation Myocardial Infarction.
     J Am Coll Cardiol. 2022;79:311-323.
     PubMed     Abstract available
     
     
     
427. YU Z, Zekavat SM, Honigberg MC, Natarajan P, et al
     Genetic IL-6 Signaling Modifies Incident Coronary Artery Disease Risk in Chronic Kidney Disease.
     J Am Coll Cardiol. 2022;79:415-416.
     PubMed    
     
     
     
428. BARRABES JA, Soriano-Colome T, Ferreira-Gonzalez I
     When Time Is Not Muscle, Yet It Still May Be Important.
     J Am Coll Cardiol. 2022;79:324-326.
     PubMed    
     
     
     January 2022
429. NAIDU SS, Baran DA, Jentzer JC, Hollenberg SM, et al
     SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Associa
     J Am Coll Cardiol. 2022 Jan 28. pii: S0735-1097(22)00180.
     PubMed    
     
     
     
430. LOCCOH EC, Joynt Maddox KE, Wang Y, Kazi DS, et al
     Rural-Urban Disparities in Outcomes of Myocardial Infarction, Heart Failure, and Stroke in the United States.
     J Am Coll Cardiol. 2022;79:267-279.
     PubMed     Abstract available
     
     
     
431. FANAROFF AC, Evans PT, Nathan AS
     Rural-Urban Disparities in Cardiovascular Outcomes: Getting to the Root of the Problem.
     J Am Coll Cardiol. 2022;79:280-282.
     PubMed    
     
     
     
432. WALSH MN
     Change in Lifetime Risk of Heart Failure: Applicable to All?
     J Am Coll Cardiol. 2022;79:264-266.
     PubMed    
     
     
     
433. KAISER Y, Daghem M, Tzolos E, Meah MN, et al
     Association of Lipoprotein(a) With Atherosclerotic Plaque Progression.
     J Am Coll Cardiol. 2022;79:223-233.
     PubMed     Abstract available
     
     
     
434. LI T, Zhang Y, He MZ, Shi X, et al
     Reply: Cardiovascular Disease Is the Condition, Air Pollution the Risk Factor, Fossil Fuel Combustion the Cause.
     J Am Coll Cardiol. 2022;79:e133.
     PubMed    
     
     
     
435. JACOBSEN AP, Blumenthal RS
     Cardiovascular Disease Is the Condition, Air Pollution the Risk Factor, Fossil Fuel Combustion the Cause.
     J Am Coll Cardiol. 2022;79:e131.
     PubMed    
     
     
     
436. VOLGMAN AS, Nair G, Lyubarova R, Merchant FM, et al
     Management of Atrial Fibrillation in Patients 75 Years and Older: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;79:166-179.
     PubMed     Abstract available
     
     
     
437. BERRY C, Ibanez B
     Intramyocardial Hemorrhage: The Final Frontier for Preventing Heart Failure Post-Myocardial Infarction.
     J Am Coll Cardiol. 2022;79:49-51.
     PubMed    
     
     
     
438. DAWSON LP, Lum M, Nerleker N, Nicholls SJ, et al
     Coronary Atherosclerotic Plaque Regression: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;79:66-82.
     PubMed     Abstract available
     
     
     
439. FLORIO KL, Grodzinsky A
     Cardiovascular Indexes in the Era of Preeclampsia: Prevention or Long-Term Outcome Prediction?
     J Am Coll Cardiol. 2022;79:63-65.
     PubMed    
     
     
     
440. CHEN X, Fu S, Xu W
     Association Between Metoprolol and Prognosis of COVID-19 Patients.
     J Am Coll Cardiol. 2022;79:e7.
     PubMed    
     
     
     
441. LIU T, Howarth AG, Chen Y, Nair AR, et al
     Intramyocardial Hemorrhage and the "Wave Front" of Reperfusion Injury Compromising Myocardial Salvage.
     J Am Coll Cardiol. 2022;79:35-48.
     PubMed     Abstract available
     
     
     December 2021
442. GRINES CL, Marshall JJ
     Early Discharge After ST-Segment Elevation Myocardial Infarction: The Days Are Getting Shorter!
     J Am Coll Cardiol. 2021;78:2561-2562.
     PubMed    
     
     
     
443. RATHOD KS, Comer K, Casey-Gillman O, Moore L, et al
     Early Hospital Discharge Following PCI for Patients With STEMI.
     J Am Coll Cardiol. 2021;78:2550-2560.
     PubMed     Abstract available
     
     
     
444. MITAL R, Bayne J, Rodriguez F, Ovbiagele B, et al
     Race and Ethnicity Considerations in Patients With Coronary Artery Disease and Stroke: JACC Focus Seminar 3/9.
     J Am Coll Cardiol. 2021;78:2483-2492.
     PubMed     Abstract available
     
     
     
445. JOSEPH JJ, Ortiz R, Acharya T, Golden SH, et al
     Cardiovascular Impact of Race and Ethnicity in Patients With Diabetes and Obesity: JACC Focus Seminar 2/9.
     J Am Coll Cardiol. 2021;78:2471-2482.
     PubMed     Abstract available
     
     
     
446. MENSAH GA, Fuster V
     Race, Ethnicity, and Cardiovascular Disease: JACC Focus Seminar Series.
     J Am Coll Cardiol. 2021;78:2457-2459.
     PubMed    
     
     
     
447. COOPER JG, Ferguson J, Donaldson LA, Black KMM, et al
     Could High-Sensitivity Cardiac Troponin Testing Rule Out Acute Myocardial Infarction in the Prehospital Setting?
     J Am Coll Cardiol. 2021;78:2392-2394.
     PubMed    
     
     
     
448. EBERLY LA, Julien H, Adusumalli S
     Weaving Antiracism Practice and Equity Into the Fabric of Cardiovascular Fellowship: A New Training Paradigm.
     J Am Coll Cardiol. 2021;78:2382-2386.
     PubMed    
     
     
     
449. CASALE PN, Perez C, Hagan EP, Roiland RA, et al
     Aligning Care and Payment for Chronic Cardiovascular Conditions.
     J Am Coll Cardiol. 2021;78:2377-2381.
     PubMed    
     
     
     
450. REFAAT MM, Gharios C, Moorthy MV, Abdulhai F, et al
     Exercise-Induced Ventricular Ectopy and Cardiovascular Mortality in Asymptomatic Individuals.
     J Am Coll Cardiol. 2021;78:2267-2277.
     PubMed     Abstract available
     
     
     
451. LAWTON JS, Tamis-Holland JE, Bangalore S, Bates ER, et al
     2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     J Am Coll Cardiol. 2021 Dec 7. pii: S0735-1097(21)06157.
     PubMed     Abstract available
     
     
     
452. LAWTON JS, Tamis-Holland JE, Bangalore S, Bates ER, et al
     2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     J Am Coll Cardiol. 2021 Dec 7. pii: S0735-1097(21)06158.
     PubMed     Abstract available
     
     
     November 2021
453. GANDHI PU, Windish DM
     Heart Failure Biomarker Education: An Unmet Need in Cardiovascular Fellowship Training.
     J Am Coll Cardiol. 2021;78:2265-2266.
     PubMed    
     
     
     
454. NATHAN AS, Manandhar P, Wojdyla D, Nelson A, et al
     Hospital-Level Percutaneous Coronary Intervention Performance With Simulated Risk Avoidance.
     J Am Coll Cardiol. 2021;78:2213-2217.
     PubMed    
     
     
     
455. GIRI J, Fanaroff AC
     1 Month of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: The New Standard?
     J Am Coll Cardiol. 2021;78:2073-2075.
     PubMed    
     
     
     
456. ZHANG J, Bolli R, Garry DJ, Marban E, et al
     Basic and Translational Research in Cardiac Repair and Regeneration: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;78:2092-2105.
     PubMed     Abstract available
     
     
     
457. HONDA Y, Mok Y, Ishigami J, Ashley KE, et al
     The Fifth-Generation Cardiac Troponin T and Cardiovascular Disease in the Community.
     J Am Coll Cardiol. 2021;78:2019-2021.
     PubMed    
     
     
     
458. DAVIDSON BP, Hodovan J, Layoun ME, Golwala H, et al
     Echocardiographic Ischemic Memory Molecular Imaging for Point-of-Care Detection of Myocardial Ischemia.
     J Am Coll Cardiol. 2021;78:1990-2000.
     PubMed     Abstract available
     
     
     
459. KITAGAWA K, Nakamura S, Ota H, Ogawa R, et al
     Diagnostic Performance of Dynamic Myocardial Perfusion Imaging Using Dual-Source Computed Tomography.
     J Am Coll Cardiol. 2021;78:1937-1949.
     PubMed     Abstract available
     
     
     
460. DAGAN M, Dinh DT, Stehli J, Zaman S, et al
     Impact of Age and Sex on Treatment and Outcomes Following Myocardial Infarction.
     J Am Coll Cardiol. 2021;78:1934-1936.
     PubMed    
     
     
     
461. LINDLEY KJ, Aggarwal NR, Briller JE, Davis MB, et al
     Socioeconomic Determinants of Health and Cardiovascular Outcomes in Women: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2021;78:1919-1929.
     PubMed     Abstract available
     
     
     
462. PALM J, Holdenrieder S, Hoffmann G, Horer J, et al
     Predicting Major Adverse Cardiovascular Events in Children With Age-Adjusted NT-proBNP.
     J Am Coll Cardiol. 2021;78:1890-1900.
     PubMed     Abstract available
     
     
     
463. RIOUFOL G, Derimay F, Roubille F, Perret T, et al
     Fractional Flow Reserve to Guide Treatment of Patients With Multivessel Coronary Artery Disease.
     J Am Coll Cardiol. 2021;78:1875-1885.
     PubMed     Abstract available
     
     
     
464. DAUERMAN HL, Tijssen JGP, Montalescot G
     The Enduring Legacy of Failed Revascularization Trials.
     J Am Coll Cardiol. 2021;78:1886-1889.
     PubMed    
     
     
     
465. BARAC A, Sharon E
     From Detecting Signals to Understanding Cardiovascular Toxicities of Cancer Therapies: All the Light We Could See.
     J Am Coll Cardiol. 2021;78:1814-1816.
     PubMed    
     
     
     
466. GOLDMAN A, Maor E, Bomze D, Liu JE, et al
     Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy.
     J Am Coll Cardiol. 2021;78:1800-1813.
     PubMed     Abstract available
     
     
     
467. WANNER PM, Wulff DU, Djurdjevic M, Korte W, et al
     Targeting Higher Intraoperative Blood Pressures Does Not Reduce Adverse Cardiovascular Events Following Noncardiac Surgery.
     J Am Coll Cardiol. 2021;78:1753-1764.
     PubMed     Abstract available
     
     
     
468. OLA O, Mehta RA, Hodge DO, Jaffe AS, et al
     Reply: Applying High-Sensitivity Cardiac Troponin T.
     J Am Coll Cardiol. 2021;78:e149-e150.
     PubMed    
     
     
     
469. GLARNER N, Lopez-Ayala P, Cakal H, Grossenbacher M, et al
     Applying High-Sensitivity Cardiac Troponin T.
     J Am Coll Cardiol. 2021;78:e147.
     PubMed    
     
     
     October 2021
470. ITOGA NK, Tawfik DS, Montez-Rath ME, Chang TI, et al
     Contributions of Systolic and Diastolic Blood Pressures to Cardiovascular Outcomes in the ALLHAT Study.
     J Am Coll Cardiol. 2021;78:1671-1678.
     PubMed     Abstract available
     
     
     
471. LIU M, Figueroa JF, Song Y, Wadhera RK, et al
     Mortality and Postdischarge Acute Care Utilization for Cardiovascular Conditions at Safety-Net Versus Non-Safety-Net Hospitals.
     J Am Coll Cardiol. 2021 Oct 26. pii: S0735-1097(21)07800.
     PubMed    
     
     
     
472. DZAYE O, Razavi AC, Dardari ZA, Shaw LJ, et al
     Modeling the Recommended Age for Initiating Coronary Artery Calcium Testing Among At-Risk Young Adults.
     J Am Coll Cardiol. 2021;78:1573-1583.
     PubMed     Abstract available
     
     
     
473. NAQVI TZ, Polonsky TS
     Finding the Right Age for CAC Testing: How Low Should You Go?
     J Am Coll Cardiol. 2021;78:1584-1586.
     PubMed    
     
     
     
474. PATEL AR, Salerno M, Kwong RY, Singh A, et al
     Stress Cardiac Magnetic Resonance Myocardial Perfusion Imaging: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2021;78:1655-1668.
     PubMed     Abstract available
     
     
     
475. SULLIVAN AE, Nanna MG, Wang TY, Bhatt DL, et al
     Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2021;78:1550-1563.
     PubMed     Abstract available
     
     
     
476. DE BRUYNE B, Pijls NHJ, Gallinoro E, Candreva A, et al
     Microvascular Resistance Reserve for Assessment of Coronary Microvascular Function: JACC Technology Corner.
     J Am Coll Cardiol. 2021;78:1541-1549.
     PubMed     Abstract available
     
     
     
477. LEE HH, Lee H, Cho SMJ, Kim DW, et al
     On-Treatment Blood Pressure and Cardiovascular Outcomes in Adults With Hypertension and Left Ventricular Hypertrophy.
     J Am Coll Cardiol. 2021;78:1485-1495.
     PubMed     Abstract available
     
     
     
478. GREENE SJ, Butler J
     Investigator-Reported Versus Adjudicated Clinical Events: 2 Versions of the Truth?
     J Am Coll Cardiol. 2021;78:1538-1540.
     PubMed    
     
     
     
479. GABA P, Bhatt DL, Giugliano RP, Steg PG, et al
     Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-IT.
     J Am Coll Cardiol. 2021;78:1525-1537.
     PubMed     Abstract available
     
     
     
480. OYAMA K, Giugliano RP, Blazing MA, Park JG, et al
     Baseline Low-Density Lipoprotein Cholesterol and Clinical Outcomes of Combining Ezetimibe With Statin Therapy in IMPROVE-IT.
     J Am Coll Cardiol. 2021;78:1499-1507.
     PubMed     Abstract available
     
     
     
481. DE KONING MLY, Westenbrink BD, Assa S, Garcia E, et al
     Association of Circulating Ketone Bodies With Functional Outcomes After ST-Segment Elevation Myocardial Infarction.
     J Am Coll Cardiol. 2021;78:1421-1432.
     PubMed     Abstract available
     
     
     
482. LEE KK, Bularga A, O'Brien R, Ferry AV, et al
     Troponin-Guided Coronary Computed Tomographic Angiography After Exclusion of Myocardial Infarction.
     J Am Coll Cardiol. 2021;78:1407-1417.
     PubMed     Abstract available
     
     
     
483. JANSEN TPJ, Konst RE, Elias-Smale SE, van den Oord SC, et al
     Assessing Microvascular Dysfunction in Angina With Unobstructed Coronary Arteries: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2021;78:1471-1479.
     PubMed     Abstract available
     
     
     
484. MARTINEZ MW, Kim JH, Shah AB, Phelan D, et al
     Exercise-Induced Cardiovascular Adaptations and Approach to Exercise and Cardiovascular Disease: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;78:1453-1470.
     PubMed     Abstract available
     
     
     September 2021
485. MERAJ PM, O'Neill WW
     Cardiogenic Shock Management Should Be a Team Sport.
     J Am Coll Cardiol. 2021;78:1318-1320.
     PubMed    
     
     
     
486. PAPOLOS AI, Kenigsberg BB, Berg DD, Alviar CL, et al
     Management and Outcomes of Cardiogenic Shock in Cardiac ICUs With Versus Without Shock Teams.
     J Am Coll Cardiol. 2021;78:1309-1317.
     PubMed     Abstract available
     
     
     
487. KASTRATI A, Coughlan JJ, Ndrepepa G
     Primary PCI, Late Presenting STEMI, and the Limits of Time.
     J Am Coll Cardiol. 2021;78:1306-1308.
     PubMed    
     
     
     
488. BOUISSET F, Gerbaud E, Bataille V, Coste P, et al
     Percutaneous Myocardial Revascularization in Late-Presenting Patients With STEMI.
     J Am Coll Cardiol. 2021;78:1291-1305.
     PubMed     Abstract available
     
     
     
489. BHATIA HS, Yeang C, Baruch A, Yang X, et al
     PCSK9 Inhibition and Oxidized Phospholipids.
     J Am Coll Cardiol. 2021;78:1288-1289.
     PubMed    
     
     
     
490. ADRIAENSSENS T, Allard-Ratick MP, Thondapu V, Sugiyama T, et al
     Optical Coherence Tomography of Coronary Plaque Progression and Destabilization: JACC Focus Seminar Part 3/3.
     J Am Coll Cardiol. 2021;78:1275-1287.
     PubMed     Abstract available
     
     
     
491. KOLTE D, Yonetsu T, Ye JC, Libby P, et al
     Optical Coherence Tomography of Plaque Erosion: JACC Focus Seminar Part 2/3.
     J Am Coll Cardiol. 2021;78:1266-1274.
     PubMed     Abstract available
     
     
     
492. DEFILIPPIS AP, Hall ME
     Impact of New ICD Codes on Acute MI Characteristics and Outcomes: What You Call It Matters.
     J Am Coll Cardiol. 2021;78:1254-1256.
     PubMed    
     
     
     
493. MCCARTHY CP, Kolte D, Kennedy KF, Pandey A, et al
     Hospitalizations and Outcomes of T1MI Observed Before and After the Introduction of MI Subtype Codes.
     J Am Coll Cardiol. 2021;78:1242-1253.
     PubMed     Abstract available
     
     
     
494. SQUIERS JJ, DiMaio JM
     SYNTAX Score II 2020: A Remake Worth the Price of Admission?
     J Am Coll Cardiol. 2021;78:1239-1241.
     PubMed    
     
     
     
495. PANZA JA, Chrzanowski L, Bonow RO
     Myocardial Viability Assessment Before Surgical Revascularization in Ischemic Cardiomyopathy: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2021;78:1068-1077.
     PubMed     Abstract available
     
     
     August 2021
496. VIRANI SS, Morris PB, Agarwala A, Ballantyne CM, et al
     2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia: A Report of the American College of Cardiology Solution Set Oversight Committee.
     J Am Coll Cardiol. 2021;78:960-993.
     PubMed    
     
     
     
497. WU EB, Brilakis ES, Mashayekhi K, Tsuchikane E, et al
     Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;78:840-853.
     PubMed     Abstract available
     
     
     
498. SCHWARTZ GG, Szarek M, Bittner VA, Diaz R, et al
     Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.
     J Am Coll Cardiol. 2021;78:421-433.
     PubMed     Abstract available
     
     
     July 2021
499. TRUDEL X, Brisson C, Talbot D, Gilbert-Ouimet M, et al
     Reply: Job Strain and Recurrent Coronary Events.
     J Am Coll Cardiol. 2021;78:419.
     PubMed    
     
     
     
500. LI J, Xin Y
     Job Strain and Recurrent Coronary Events.
     J Am Coll Cardiol. 2021;78:418-419.
     PubMed    
     
     
     
501. MACK MJ, Squiers JJ, Lytle BW, DiMaio JM, et al
     Myocardial Revascularization Surgery: JACC Historical Breakthroughs in Perspective.
     J Am Coll Cardiol. 2021;78:365-383.
     PubMed     Abstract available
     
     
     
502. BRENER SJ
     Refinements in Predicting In-Hospital Mortality Following PCI: The Science and Art of Competing Risk Analysis.
     J Am Coll Cardiol. 2021;78:230-233.
     PubMed    
     
     
     June 2021
503. GANGULI I, Cui J, Thakore N, Orav EJ, et al
     Downstream Cascades of Care Following High-Sensitivity Troponin Test Implementation.
     J Am Coll Cardiol. 2021;77:3171-3179.
     PubMed     Abstract available
     
     
     
504. OLA O, Akula A, De Michieli L, Dworak M, et al
     Clinical Impact of High-Sensitivity Cardiac Troponin T Implementation in the Community.
     J Am Coll Cardiol. 2021;77:3160-3170.
     PubMed     Abstract available
     
     
     
505. GRAHAM IM, Di Angelantonio E, Visseren F, De Bacquer D, et al
     Systematic Coronary Risk Evaluation (SCORE): JACC Focus Seminar 4/8.
     J Am Coll Cardiol. 2021;77:3046-3057.
     PubMed     Abstract available
     
     
     
506. BARTHELEMY O, Rouanet S, Zeymer U, Thiele H, et al
     Reply: The Residual SYNTAX Score: A Useful Tool to Predict Outcomes in Cardiogenic Shock.
     J Am Coll Cardiol. 2021;77:2872-2873.
     PubMed    
     
     
     
507. LI X, Ni S
     Could Residual SYNTAX Score Predict the Prognosis of Patients With Cardiogenic Shock?
     J Am Coll Cardiol. 2021;77:2872.
     PubMed    
     
     
     
508. BURGESS SN, Juergens CP, Mussap CJ, Lo STH, et al
     Cardiogenic Shock, the Residual SYNTAX Score, and Prognosis: Corroborative "Real-World" Data.
     J Am Coll Cardiol. 2021;77:2871-2872.
     PubMed    
     
     
     
509. BROUWERS RWM, Kraal JJ, Regis M, Spee RF, et al
     Effectiveness of Cardiac Telerehabilitation With Relapse Prevention: SmartCare-CAD Randomized Controlled Trial.
     J Am Coll Cardiol. 2021;77:2754-2756.
     PubMed    
     
     
     
510. ANDERSSON C, Nayor M, Tsao CW, Levy D, et al
     Framingham Heart Study: JACC Focus Seminar, 1/8.
     J Am Coll Cardiol. 2021;77:2680-2692.
     PubMed     Abstract available
     
     
     May 2021
511. LEITER LA, Bhatt DL, McGuire DK, Teoh H, et al
     Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI Trials.
     J Am Coll Cardiol. 2021;77:2366-2377.
     PubMed     Abstract available
     
     
     
512. LEBOUBE S, Paccalet A, Da Silva CC, Hayek A, et al
     Soluble C-Met as a Biomarker of Clinical Outcomes After STEMI.
     J Am Coll Cardiol. 2021;77:2348-2350.
     PubMed    
     
     
     
513. HARTIKAINEN TS, Sorensen NA, Gossling A, Haller PM, et al
     Application of the Fourth Universal Definition of MI Using FDA-Recommended Sex-Specific Troponin Cutoff Concentrations.
     J Am Coll Cardiol. 2021;77:2346-2348.
     PubMed    
     
     
     
514. GRUBERG L, Gandotra P
     STEMI Following TAVR: Unusual But Definitely Not Trivial.
     J Am Coll Cardiol. 2021;77:2200-2203.
     PubMed    
     
     
     
515. VINCIGUERRA M, Spadaccio C, Tennyson C, Karuppannan M, et al
     Management of Patients With Aortocoronary Saphenous Vein Graft Aneurysms: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;77:2236-2253.
     PubMed     Abstract available
     
     
     
516. HERZOG CA, Simegn MA, Xu Y, Costa SR, et al
     Kidney Transplant List Status and Outcomes in the ISCHEMIA-CKD Trial.
     J Am Coll Cardiol. 2021 May 4. pii: S0735-1097(21)04965.
     PubMed     Abstract available
     
     
     April 2021
517. MORLEY-SMITH A, Quinn D, Lim HS
     Temporary Mechanical Circulatory Support: An Intervention in Need of a Strategy.
     J Am Coll Cardiol. 2021;77:1954.
     PubMed    
     
     
     
518. CAVALLARI I, Bhatt DL, Steg PG, Leiter LA, et al
     Causes and Risk Factors for Death in Diabetes: A Competing-Risk Analysis From the SAVOR-TIMI 53 Trial.
     J Am Coll Cardiol. 2021;77:1837-1840.
     PubMed    
     
     
     
519. TRUDEL X, Brisson C, Talbot D, Gilbert-Ouimet M, et al
     Long Working Hours and Risk of Recurrent Coronary Events.
     J Am Coll Cardiol. 2021;77:1616-1625.
     PubMed     Abstract available
     
     
     March 2021
520. JOHANNESEN CDL, Mortensen MB, Langsted A, Nordestgaard BG, et al
     Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients.
     J Am Coll Cardiol. 2021;77:1439-1450.
     PubMed     Abstract available
     
     
     
521. BOS D, Arshi B, van den Bouwhuijsen QJA, Ikram MK, et al
     Atherosclerotic Carotid Plaque Composition and Incident Stroke and Coronary Events.
     J Am Coll Cardiol. 2021;77:1426-1435.
     PubMed     Abstract available
     
     
     
522. BOEDDINGHAUS J, Nestelberger T, Lopez-Ayala P, Koechlin L, et al
     Diagnostic Performance of the European Society of Cardiology 0/1-h Algorithms in Late Presenters.
     J Am Coll Cardiol. 2021;77:1264-1267.
     PubMed    
     
     
     
523. BALTHAZAR T, Vandenbriele C, Verbrugge FH, Den Uil C, et al
     Managing Patients With Short-Term Mechanical Circulatory Support: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2021;77:1243-1256.
     PubMed     Abstract available
     
     
     
524. IKEDA G, Santoso MR, Tada Y, Li AM, et al
     Mitochondria-Rich Extracellular Vesicles From Autologous Stem Cell-Derived Cardiomyocytes Restore Energetics of Ischemic Myocardium.
     J Am Coll Cardiol. 2021;77:1073-1088.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.